To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene OGFOD2andARL6IP4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
709 representative clones for gene OGFOD2andARL6IP4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA313353 colon .vv 84 to 565 1 to 482       482/482
(100 %)
0 diff
(100 %id)
AA316945 colon .d 826 to 1236 1 to 411       411/411
(100 %)
0 diff
(100 %id)
AA339215 brain .b 1321 to 1622 1 to 304       304/304
(100 %)
4 diff
(98.7 %id)
AA354016   .f 581 to 775 1 to 193       193/193
(100 %)
4 diff
(98.0 %id)
AA371829 pituitary gland .e 1146 to 1395 250 to 1     Submitted on the opposite strand 250/250
(100 %)
0 diff
(100 %id)
AA371960 pituitary gland .e 1044 to 1393 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AA371961 pituitary gland .e 1044 to 1393 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AB035384   .c 637 to 1588 1 to 952       952/952
(100 %)
1 diff
(99.9 %id)
AB040953 brain .b 3206 to 5362 2157 to 1   tiling clone, available from KIAA, Submitted on the opposite strand 2157/2157
(100 %)
2 diff
(100.0 %id)
AF267748 lung .vf 1 to 889 1 to 888 K149N L150* tiling clone, AAA   888/888
(100 %)
9 diff
(99.0 %id)
AJ573801 pectoral muscle (after mastectomy) .e 1104 to 1397 15 to 308   AAA   294/308
(95 %)
5 diff
(98.4 %id)
AK023553 placenta .n 1 to 2079 2 to 2080 exact tiling clone, available from FLJ,   2080/2080
(100 %)
3 diff
(99.9 %id)
AK027285 whole embryo, mainly head .wr 1 to 1369 2 to 1371   tiling clone, available from FLJ,   1371/1371
(100 %)
5 diff
(99.7 %id)
AK074098 Spleen .b 532 to 6149 1 to 5618 exact tiling clone, available from FLJ,   5618/5618
(100 %)
3 diff
(100.0 %id)
AK094820 brain .f 529 to 2308 1 to 1780 exact tiling clone, available from FLJ,   1780/1780
(100 %)
1 diff
(100.0 %id)
AK095481   .wn 67 to 1954 1 to 1888 N80S tiling clone, available from FLJ,   1888/1888
(100 %)
4 diff
(99.8 %id)
AK303095 thymus .vu 1 to 1039 1 to 1039 exact tiling clone,   1039/1039
(100 %)
0 diff
(100 %id)
AK315759 trachea .c 646 to 1355 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
AW380212 head_neck .b 5445 to 5786 351 to 6       351/362
(96 %)
8 diff
(97.8 %id)
AW380214 head_neck .b 5444 to 5775 338 to 10       329/348
(94 %)
2 diff
(99.5 %id)
AW380336 head_neck .d 719 to 1101 1 to 384       384/386
(99 %)
15 diff
(96.2 %id)
AW605975 head_neck .d 754 to 1101 7 to 357       351/359
(97 %)
14 diff
(96.2 %id)
AW821051 stomach .c 814 to 1020 220 to 15       206/220
(93 %)
0 diff
(100 %id)
AW973635   .e 897 to 1392 496 to 1     Submitted on the opposite strand 496/496
(100 %)
7 diff
(98.6 %id)
BG944525 blood .e 1193 to 1395 233 to 31   AAA   203/203
(100 %)
3 diff
(98.6 %id)
BC001958 Skin, melanotic melanoma. .c 668 to 1586 1 to 919   available from MGC, AAA   919/919
(100 %)
0 diff
(100 %id)
BC015569 Uterus, endometrium adenocarcinoma .e 398 to 1393 1 to 996   tiling clone, available from MGC, AAA   996/996
(100 %)
0 diff
(100 %id)
BC015909 Eye, retinoblastoma .a 1 to 1644 1 to 1644 exact tiling clone, available from MGC, AAA   1644/1644
(100 %)
0 diff
(100 %id)
BC094839 Brain, neuroblastoma .d 1 to 1354 1 to 1354 S119P tiling clone, AAA   1354/1354
(100 %)
1 diff
(100.0 %id)
BC098119 PCR rescued clones .wg 269 to 1949 1 to 1681 exact     1681/1681
(100 %)
1 diff
(100.0 %id)
BC098293 PCR rescued clones .wg 269 to 1949 1 to 1681 exact tiling clone,   1681/1681
(100 %)
0 diff
(100 %id)
BC101940 PCR rescued clones .i 198 to 1685 1 to 1488 A296T tiling clone,   1488/1488
(100 %)
1 diff
(100.0 %id)
BC105637 PCR rescued clones .i 198 to 1685 1 to 1488 exact tiling clone,   1488/1488
(100 %)
1 diff
(100.0 %id)
BE693714 breast .b 5403 to 5778 373 to 1       373/373
(100 %)
9 diff
(97.6 %id)
BE774161 uterus .c 816 to 1026 231 to 21       211/231
(91 %)
0 diff
(100 %id)
BE933227 head_neck .f 1848 to 2284 439 to 3       437/439
(99 %)
0 diff
(100 %id)
BF155300 breast .wn 417 to 925 1 to 508       508/530
(95 %)
8 diff
(98.5 %id)
BF229851 colon_est .vt 551 to 920 1 to 366       366/380
(96 %)
9 diff
(97.7 %id)
BF759244 colon .d 875 to 1163 292 to 1     Submitted on the opposite strand 292/292
(100 %)
11 diff
(96.3 %id)
BF759262 colon .d 938 to 1168 231 to 1     Submitted on the opposite strand 231/231
(100 %)
4 diff
(98.3 %id)
BF759277 colon .d 924 to 1245 1 to 322       322/327
(98 %)
9 diff
(97.3 %id)
BF759291 colon .e 833 to 1139 6 to 310       305/310
(98 %)
8 diff
(97.5 %id)
BF850031 lung_normal .d 481 to 942 462 to 1     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
BF850163 lung_normal .b 5393 to 5663 281 to 11     Submitted on the opposite strand 271/281
(96 %)
5 diff
(98.3 %id)
BF877067 lung_tumor .b 5064 to 5552 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
BF920233 nervous_tumor .k 1001 to 1239 22 to 260       239/260
(91 %)
6 diff
(97.7 %id)
BF929249 nervous_tumor .g 1134 to 1589 20 to 475       456/475
(96 %)
6 diff
(98.8 %id)
BF932943 nervous_tumor .b 2196 to 2339 1 to 144       144/144
(100 %)
1 diff
(99.4 %id)
BI022922 marrow .g 1188 to 1493 1 to 306       306/306
(100 %)
5 diff
(98.4 %id)
BQ319418 colon .d 873 to 1124 256 to 1       256/259
(98 %)
10 diff
(96.2 %id)
BQ319419 colon .d 846 to 1186 1 to 343       343/343
(100 %)
12 diff
(96.6 %id)
BQ361282 ovary .b 3083 to 3380 1 to 298       298/313
(95 %)
4 diff
(98.8 %id)
BQ694733 adipose .b 4451 to 4932 1 to 479       479/479
(100 %)
6 diff
(98.8 %id)
DA060410 cerebellum .f 554 to 1119 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA068355 cerebellum .ws 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DC317389 amygdala .b 1 to 483 6 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DA208736 brain .f 530 to 751 2 to 223   capped   222/222
(100 %)
0 diff
(100 %id)
DB304292 brain .f 1778 to 2308 531 to 1       531/531
(100 %)
0 diff
(100 %id)
DA262206 caudate nucleus .wo 28 to 588 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA264069 caudate nucleus .f 559 to 1113 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA277322 corpus callosum .f 554 to 1110 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA344308 substantia nigra .f 554 to 1048 2 to 497   capped   496/496
(100 %)
1 diff
(99.8 %id)
DA399111 thalamus .ve 209 to 771 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BF725773 eye, Iris .u 21 to 541 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BF726010 eye, Iris .c 680 to 797 1 to 118       118/118
(100 %)
0 diff
(100 %id)
BX093055 whole brain .f 1920 to 2308 403 to 15   AAA   389/389
(100 %)
1 diff
(99.8 %id)
BX113885 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 914 to 1352 453 to 15   AAA   439/439
(100 %)
0 diff
(100 %id)
BX640675 colon endothel, primary cell culture .f 540 to 1719 1 to 1180 N244S tiling clone, available from DKFZ, AAA   1180/1180
(100 %)
2 diff
(99.9 %id)
BX640734 human fetal liver .wp 1 to 1827 1 to 1825 W123A P125E S126F S127L W128A ... tiling clone, available from DKFZ, AAA   1825/1825
(100 %)
5 diff
(99.8 %id)
CD632167   .wn 584 to 946 1 to 364       364/376
(96 %)
6 diff
(98.5 %id)
CD632168   .wn 590 to 946 369 to 12       358/375
(95 %)
0 diff
(100 %id)
CN274246 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 526 to 748 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
CN275316 embryonic stem cells, DMSO-treated H9 cellline .s 585 to 1120 9 to 545   tiling clone,   537/545
(98 %)
7 diff
(98.8 %id)
CN283750 embryonic stem cells, cell lines H1, H7, andH9 .wt-u 26 to 350 1 to 325       325/325
(100 %)
2 diff
(99.4 %id)
CN299698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 48 to 338 1 to 291       291/291
(100 %)
0 diff
(100 %id)
CN336757 embryonic stem cells, DMSO-treated H9 cellline .a 687 to 1146 1 to 460       460/460
(100 %)
0 diff
(100 %id)
CN336758 embryonic stem cells, cell lines H1, H7, andH9 .l 251 to 953 1 to 703   tiling clone,   703/703
(100 %)
0 diff
(100 %id)
CN336759 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 642 to 1250 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
CN336760 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 886 to 1307 1 to 422       422/422
(100 %)
0 diff
(100 %id)
CN336761 embryonic stem cells, cell lines H1, H7, andH9 .a 653 to 1152 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
CN336762 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .wa 1 to 455 1 to 455   tiling clone,   455/455
(100 %)
2 diff
(99.6 %id)
CN336763 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 632 to 978 1 to 348       348/348
(100 %)
5 diff
(98.6 %id)
CN336764 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 665 to 1197 1 to 533       533/533
(100 %)
0 diff
(100 %id)
CN336765 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 668 to 1370 7 to 709       703/709
(99 %)
6 diff
(99.2 %id)
CN336766 embryonic stem cells, DMSO-treated H9 cellline .c 665 to 1200 4 to 541       538/541
(99 %)
7 diff
(98.8 %id)
CN336767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .wd 1 to 486 1 to 486 exact tiling clone,   486/486
(100 %)
0 diff
(100 %id)
CN337730 embryonic stem cells, DMSO-treated H9 cellline .f 629 to 995 1 to 367       367/367
(100 %)
0 diff
(100 %id)
CN337731 embryonic stem cells, cell lines H1, H7, andH9 .k 36 to 768 8 to 742       735/742
(99 %)
7 diff
(99.1 %id)
CN337732 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3600 to 4299 701 to 2     Submitted on the opposite strand 700/701
(99 %)
0 diff
(100 %id)
CN337733 embryonic stem cells, DMSO-treated H9 cellline .f 548 to 1058 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
CN337734 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2513 to 3116 1 to 604       604/604
(100 %)
0 diff
(100 %id)
CN337735 embryonic stem cells, cell lines H1, H7, andH9 .b 3902 to 4367 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
CN337736 embryonic stem cells, cell lines H1, H7, andH9 .b 4136 to 4257 1 to 122       122/122
(100 %)
0 diff
(100 %id)
CR457316   .n 512 to 1380 1 to 869       869/873
(99 %)
1 diff
(99.9 %id)
CR599283 thymus .a 623 to 1613 1 to 991       991/991
(100 %)
0 diff
(100 %id)
CR600790 fetal brain .g 1 to 1782 1 to 1782 exact tiling clone,   1782/1782
(100 %)
0 diff
(100 %id)
CR607411 fetal liver .k 11 to 1678 1 to 1668   tiling clone,   1668/1668
(100 %)
0 diff
(100 %id)
CR608335 B cells (Ramos cell line) .c 740 to 1588 1 to 849       849/849
(100 %)
0 diff
(100 %id)
CR610399 Placenta Cot 25-normalized .wk 1 to 1341 1 to 1341 exact tiling clone,   1341/1341
(100 %)
0 diff
(100 %id)
CR612958 Neuroblastoma Cot 25-normalized .vd 20 to 1004 1 to 985 exact tiling clone,   985/985
(100 %)
0 diff
(100 %id)
CR622052 fetal brain .j 1 to 1677 1 to 1677 exact tiling clone,   1677/1677
(100 %)
0 diff
(100 %id)
CR622109 HeLa cells Cot 25-normalized .wq 1 to 1568 1 to 1568 exact tiling clone,   1568/1568
(100 %)
0 diff
(100 %id)
CR622330 B cells (Ramos cell line) Cot 25-normalized .c 686 to 1585 1 to 900       900/900
(100 %)
0 diff
(100 %id)
CR624619 Neuroblastoma Cot 50-normalized .d 900 to 1354 1 to 455       455/455
(100 %)
0 diff
(100 %id)
CR625814 Placenta Cot 25-normalized .d 419 to 1353 1 to 935       935/935
(100 %)
0 diff
(100 %id)
CR626482 B cells (Ramos cell line) Cot 25-normalized .ve 1 to 1273 1 to 1273 exact tiling clone,   1273/1273
(100 %)
0 diff
(100 %id)
BX436896 thymus .a 1105 to 1613 511 to 1   fully sequenced,   511/511
(100 %)
2 diff
(99.7 %id)
BX436897 thymus .a 629 to 1607 8 to 971   fully sequenced,   964/971
(99 %)
26 diff
(97.4 %id)
BX350998 Neuroblastoma Cot 25-normalized .vd 619 to 981 366 to 5   fully sequenced,   362/366
(98 %)
0 diff
(100 %id)
BX375202 Neuroblastoma Cot 25-normalized .vd 20 to 999 1 to 976 G120X S145X fully sequenced,   976/976
(100 %)
11 diff
(98.9 %id)
AL528806 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .wo 1 to 895 1 to 884   tiling clone,   884/944
(93 %)
17 diff
(98.2 %id)
AL563252 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .wo 903 to 1893 974 to 1   tiling clone,   974/1028
(94 %)
21 diff
(98.0 %id)
BX333972 Neuroblastoma Cot 50-normalized .d 900 to 1354 1 to 455   fully sequenced,   455/455
(100 %)
2 diff
(99.6 %id)
BX392387 Neuroblastoma Cot 50-normalized .d 1014 to 1353 339 to 1   fully sequenced,   339/339
(100 %)
6 diff
(98.3 %id)
BX417067 placenta .d 419 to 1353 1 to 934       934/934
(100 %)
2 diff
(99.8 %id)
AL535439 brain, fetal brain .g 845 to 1775 938 to 8   fully sequenced,   931/938
(99 %)
0 diff
(100 %id)
AL535440 brain, fetal brain .g 32 to 879 33 to 878   fully sequenced,   845/877
(96 %)
14 diff
(98.5 %id)
AL536805 brain, fetal brain .j 801 to 1640 873 to 39   fully sequenced,   835/873
(95 %)
15 diff
(98.3 %id)
AL536806 brain, fetal brain .j 1 to 862 1 to 859   fully sequenced,   859/859
(100 %)
3 diff
(99.7 %id)
AL560370 B cells (Ramos cell line), B cells from Burkitt lymphoma .c 740 to 1588 1 to 849       849/849
(100 %)
3 diff
(99.7 %id)
AL543072.
matches multiple genes
placenta, Placenta Cot 25-normalized .vl 1 to 1029 1 to 1007 S48T R49E G50A C51V V52L ... tiling clone, also hits gene MUL1 1007/1066
(94 %)
16 diff
(98.5 %id)
AL569751.
matches multiple genes
placenta, Placenta Cot 25-normalized .vl 1599 to 2611 999 to 1   tiling clone, also hits gene MUL1 999/1045
(95 %)
20 diff
(98.1 %id)
BX330072 Placenta Cot 25-normalized .d 964 to 1353 389 to 1   fully sequenced,   389/389
(100 %)
4 diff
(99.0 %id)
BX378339 Placenta Cot 25-normalized .d 419 to 1351 1 to 924   fully sequenced,   924/924
(100 %)
14 diff
(98.5 %id)
BX339147 Placenta Cot 25-normalized .wk 624 to 1303 727 to 38   fully sequenced,   690/727
(94 %)
0 diff
(100 %id)
BX339148 Placenta Cot 25-normalized .wk 1 to 684 1 to 685 S48T R49E G50A C51V V52L ... fully sequenced,   685/685
(100 %)
8 diff
(98.9 %id)
BX399916 Placenta Cot 25-normalized .b 4840 to 5586 35 to 777       743/777
(95 %)
6 diff
(99.3 %id)
AL555342 placenta .wq 1 to 863 1 to 862 S33T R34E G35A C36V V37L ...     862/862
(100 %)
4 diff
(99.6 %id)
AL577870 placenta .wn 1020 to 1924 906 to 1       906/906
(100 %)
15 diff
(98.4 %id)
BX350517   .wq 698 to 1552 852 to 1       852/852
(100 %)
31 diff
(96.4 %id)
BX390735   .wq 720 to 1497 1 to 781       781/868
(89 %)
26 diff
(97.1 %id)
AL582898 B cells from Burkitt lymphoma .c 688 to 1585 1 to 897       897/897
(100 %)
15 diff
(98.4 %id)
BX385579   .ve 673 to 1273 601 to 1   fully sequenced,   601/601
(100 %)
11 diff
(98.2 %id)
BX385580   .ve 1 to 703 1 to 703   fully sequenced,   703/703
(100 %)
6 diff
(99.2 %id)
BX422286 fetal liver, Liver .k 1142 to 1621 508 to 29       480/609
(78 %)
5 diff
(99.2 %id)
BX422287 fetal liver, Liver .k 11 to 932 1 to 916       916/1040
(88 %)
14 diff
(98.7 %id)
BX431815 fetal liver, Liver .k 773 to 1378 1 to 606       606/801
(75 %)
23 diff
(97.2 %id)
BX431816 fetal liver, Liver .k 775 to 1184 1 to 409       409/841
(48 %)
4 diff
(99.6 %id)
CA391295 eye, RPE/choroid .c 653 to 1158 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CU451057 epidermis .wn 1139 to 1900 773 to 12     Submitted on the opposite strand 762/773
(98 %)
0 diff
(100 %id)
CV025964 mixed .c 699 to 1208 1 to 510       510/510
(100 %)
12 diff
(97.7 %id)
CV028939 mixed .e 425 to 1055 1 to 629       629/629
(100 %)
9 diff
(98.6 %id)
DA474622   .wn 68 to 605 2 to 542   capped   541/541
(100 %)
4 diff
(99.3 %id)
BX494599 Liver .wg 55 to 364 1 to 310       310/310
(100 %)
3 diff
(99.1 %id)
DQ099385   .vs 53 to 598 1 to 546 exact     546/546
(100 %)
0 diff
(100 %id)
DW437513 Liver .b 5555 to 5780 17 to 242       226/248
(91 %)
8 diff
(96.8 %id)
EC443536 Prostate .c 644 to 750 1 to 109       109/109
(100 %)
1 diff
(99.1 %id)
EC465395 Prostate .b 5546 to 5642 1 to 97       97/97
(100 %)
0 diff
(100 %id)
EC556383 Prostate .wn 979 to 1078 99 to 1       99/106
(93 %)
0 diff
(100 %id)
EF036485   .d 447 to 718 1 to 272       272/272
(100 %)
0 diff
(100 %id)
EL945853 eyeball .d 851 to 1099 1 to 248       248/248
(100 %)
2 diff
(99.2 %id)
EL948045 eyeball .d 873 to 1354 52 to 530   AAA   479/530
(90 %)
6 diff
(98.9 %id)
EL950494 eyeball .wn 1320 to 1794 19 to 493       475/493
(96 %)
6 diff
(98.8 %id)
ES309198 occipital hair of pubic hypotrichosispatient, skin .d 497 to 993 1 to 500       500/670
(74 %)
14 diff
(98.0 %id)
EU624490   .c 2 to 1588 1 to 1587 exact tiling clone, AAA   1587/1587
(100 %)
0 diff
(100 %id)
EU624491   .vb 1 to 1318 1 to 1318 exact tiling clone, AAA   1318/1318
(100 %)
0 diff
(100 %id)
DA541501 lung .wt-u 1 to 573 2 to 571 G43X V45G S46E G47W R48P ... tiling clone, capped   570/570
(100 %)
3 diff
(99.5 %id)
CD671917 eye, Iris .vv 19 to 633 1 to 615 S14I tiling clone,   615/615
(100 %)
1 diff
(99.9 %id)
CD672894 eye, Iris .vs 6 to 535 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BP232121 muscle .c 647 to 1126 1 to 479       479/482
(99 %)
4 diff
(99.2 %id)
CD674951 eye, lens .k 44 to 566 1 to 523       523/523
(100 %)
0 diff
(100 %id)
GD136122   .d 920 to 1354 1 to 433       433/441
(98 %)
12 diff
(97.3 %id)
BP390526 pancreatic islet .d 828 to 1247 420 to 1       420/420
(100 %)
0 diff
(100 %id)
DB447440 testis .wg 24 to 439 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
DB512413 testis .f 1912 to 2308 3 to 400     Submitted on the opposite strand 398/400
(99 %)
18 diff
(95.5 %id)
DB515403 testis .e 1247 to 1393 10 to 157     Submitted on the opposite strand 148/157
(94 %)
6 diff
(96.2 %id)
DB451115 testis .c 655 to 1131 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
DB516609 testis .d 911 to 1352 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
DB455528 testis .wg 56 to 518 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
DB520957 testis .f 1863 to 2309 1 to 447     Submitted on the opposite strand 447/449
(99 %)
1 diff
(99.8 %id)
DB521588 testis .g 1340 to 1801 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
DB459089 testis .we 1 to 479 1 to 479 N20X tiling clone,   479/479
(100 %)
0 diff
(100 %id)
DB524579 testis .f 1828 to 2308 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
DB473078 hippocampus .wt-u 2 to 472 1 to 471 exact tiling clone,   471/471
(100 %)
2 diff
(99.6 %id)
DB541834 hippocampus .b 2704 to 3160 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
DB485873 hypothalamus .d 370 to 809 1 to 438       438/438
(100 %)
9 diff
(98.0 %id)
DB486029 hypothalamus .d 370 to 647 1 to 280       280/360
(77 %)
8 diff
(97.8 %id)
DB489613 hypothalamus .c 645 to 1110 1 to 466       466/466
(100 %)
6 diff
(98.8 %id)
DB494277 hypothalamus .vk 8 to 508 1 to 501       501/501
(100 %)
0 diff
(100 %id)
DB565319 hypothalamus .f 1858 to 2308 1 to 451     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
DB495434 hypothalamus .vd 1 to 509 3 to 511   tiling clone,   511/511
(100 %)
1 diff
(99.9 %id)
DB566492 hypothalamus .d 905 to 1352 1 to 448     Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
DB497599 hypothalamus .wa 15 to 524 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
DB568698 hypothalamus .vz 309 to 797 1 to 489     Submitted on the opposite strand 489/490
(99 %)
1 diff
(99.8 %id)
DB498232 hypothalamus .c 645 to 1141 1 to 497       497/497
(100 %)
5 diff
(99.0 %id)
DB569327 hypothalamus .d 903 to 1354 1 to 452   AAA Submitted on the opposite strand 452/452
(100 %)
9 diff
(98.1 %id)
DB498937 hypothalamus .vk 8 to 506 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
DB570039 hypothalamus .f 1806 to 2308 1 to 504     Submitted on the opposite strand 504/504
(100 %)
9 diff
(98.3 %id)
DB503273 hypothalamus .c 645 to 1133 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
DB574505 hypothalamus .d 921 to 1354 1 to 434     Submitted on the opposite strand 434/443
(97 %)
1 diff
(99.8 %id)
DB504825 hypothalamus .c 645 to 1128 1 to 484       484/484
(100 %)
0 diff
(100 %id)
DB576083 hypothalamus .d 873 to 1354 1 to 482     Submitted on the opposite strand 482/491
(98 %)
1 diff
(99.8 %id)
DB505196 hypothalamus .vp 1 to 463 1 to 463   tiling clone,   463/463
(100 %)
2 diff
(99.6 %id)
DB576465 hypothalamus .d 888 to 1354 1 to 467     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
BP385809 pancreatic islet .vv 98 to 596 499 to 1       499/500
(99 %)
0 diff
(100 %id)
BP387465 pancreatic islet .d 917 to 1352 53 to 488     Submitted on the opposite strand 436/488
(89 %)
5 diff
(99.0 %id)
BQ638584 eye, retina .b 5354 to 5902 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BQ640106 eye, retina .d 610 to 1231 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BY797772 eye .d 694 to 1269 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
DA568919 whole embryo, mainly head .wr 1 to 792 2 to 794   capped   793/799
(99 %)
10 diff
(98.8 %id)
DB355494 whole embryo, mainly head .wr 807 to 1369 564 to 1 T5P E7X D10N tiling clone,   564/566
(99 %)
6 diff
(99.0 %id)
BJ994883 hepatoblastoma .c 665 to 1080 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BJ995564 hepatoblastoma .vk 1 to 435 1 to 435   tiling clone,   435/435
(100 %)
0 diff
(100 %id)
BJ995565 hepatoblastoma .vk 1237 to 1734 498 to 1   tiling clone,   498/498
(100 %)
0 diff
(100 %id)
CD679584 eye, Trabecular meshwork .f 2053 to 2308 1 to 256   AAA   256/256
(100 %)
1 diff
(99.7 %id)
R44215 whole brain .f 1979 to 2309 347 to 8       340/349
(97 %)
0 diff
(100 %id)
T56183 ovary .b 5291 to 5592 1 to 312     Submitted on the opposite strand 312/313
(99 %)
17 diff
(94.6 %id)
R90840 brain .wn 1034 to 1349 328 to 11       318/328
(96 %)
6 diff
(98.2 %id)
R90861 brain .wn 460 to 875 1 to 424       424/446
(95 %)
15 diff
(96.7 %id)
H51019 brain .wn 461 to 788 1 to 328       328/329
(99 %)
5 diff
(98.5 %id)
H51020 brain .wn 1053 to 1359 311 to 3       309/311
(99 %)
0 diff
(100 %id)
R85499 brain .wn 928 to 1345 439 to 16       424/492
(86 %)
8 diff
(98.4 %id)
H41492 brain .wn 965 to 1321 360 to 1       360/360
(100 %)
4 diff
(98.9 %id)
AA699608 liver and spleen .wn 1005 to 1348 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AA070224   .b 5307 to 5711 13 to 414     Submitted on the opposite strand 402/424
(94 %)
10 diff
(97.7 %id)
AA070326   .d 943 to 1354 416 to 4     Submitted on the opposite strand 413/441
(93 %)
5 diff
(98.9 %id)
AA114001   .e 1205 to 1379 173 to 1     Submitted on the opposite strand 173/173
(100 %)
2 diff
(98.9 %id)
AA147366   .e 961 to 1393 433 to 1       433/433
(100 %)
5 diff
(98.9 %id)
AA158374 Pancreas .c 922 to 1050 1 to 129       129/129
(100 %)
4 diff
(96.9 %id)
AA158375 Pancreas .c 1185 to 1585 403 to 3       401/403
(99 %)
1 diff
(99.8 %id)
AA486219   .c 756 to 960 1 to 205     Submitted on the opposite strand 205/205
(100 %)
1 diff
(99.6 %id)
AA668171   .b 5296 to 5754 9 to 465     Submitted on the opposite strand 457/465
(98 %)
9 diff
(98.1 %id)
AA468858 colon .c 1266 to 1588 322 to 1       322/322
(100 %)
5 diff
(98.5 %id)
AA676365   .vs 175 to 635 1 to 457     Submitted on the opposite strand 458/457
(100 %)
13 diff
(97.2 %id)
AA676459   .b 5332 to 5741 1 to 407     Submitted on the opposite strand 407/407
(100 %)
7 diff
(98.3 %id)
AA514219 colon .e 1175 to 1395 220 to 1       220/221
(99 %)
1 diff
(99.6 %id)
AA523399 lung, lung tumor .d 813 to 1354 542 to 3       540/546
(98 %)
3 diff
(99.5 %id)
AA533128 normal prostatic epithelial cells, Prostate .d 912 to 1354 466 to 26   AAA   441/447
(98 %)
28 diff
(93.8 %id)
AA531120 normal prostatic epithelial cells, Prostate .f 1961 to 2311 363 to 13   tiling clone, AAA   351/354
(99 %)
0 diff
(100 %id)
AA588052 colon, tumor .d 913 to 1354 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AA557570 colon .e 1053 to 1394 343 to 4       340/343
(99 %)
0 diff
(100 %id)
AA625305 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .wc 1 to 496 1 to 498 P35Q G36A Q66R S67A R68G ... tiling clone,   494/498
(99 %)
5 diff
(99.0 %id)
AA575985 breast, breast tumor .vz 393 to 796 402 to 1       402/402
(100 %)
8 diff
(98.1 %id)
AA617659 lung, lung tumor .d 915 to 1324 411 to 2       410/411
(99 %)
1 diff
(99.8 %id)
AA643064 epithelium (cell line), Prostate .vz 392 to 798 409 to 4       406/409
(99 %)
0 diff
(100 %id)
AA743899 Kidney .e 1149 to 1393 266 to 24   AAA   243/243
(100 %)
3 diff
(98.8 %id)
AA741217 2 pooled tumors (clear cell type), Kidney .wn 1085 to 1362 281 to 4       278/281
(98 %)
0 diff
(100 %id)
AA740682 2 pooled tumors (clear cell type), Kidney .e 1175 to 1395 223 to 4       220/223
(98 %)
0 diff
(100 %id)
AA836782 Kidney, kidney tumor .vz 392 to 796 419 to 16   AAA   404/404
(100 %)
3 diff
(99.3 %id)
AA884835 pooled .wn 1046 to 1348 316 to 14   AAA   303/303
(100 %)
0 diff
(100 %id)
AA887283 Kidney .b 5871 to 6155 293 to 10   tiling clone,   284/293
(96 %)
0 diff
(100 %id)
AI082157   .wn 931 to 1362 437 to 6       432/437
(98 %)
0 diff
(100 %id)
AI025662 parathyroid gland, parathyroid tumor .wn 890 to 1362 477 to 5       473/481
(98 %)
3 diff
(99.4 %id)
AI084216 B-cell, chronic lymphotic leukemia .e 1041 to 1395 375 to 21   AAA   355/355
(100 %)
1 diff
(99.8 %id)
AI122765 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 903 to 1353 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI264048 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1240 to 1587 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AI224114 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1325 to 1799 475 to 1       475/475
(100 %)
2 diff
(99.6 %id)
AI299499 carcinoid, lung .vz 1 to 426 4 to 429     Submitted on the opposite strand 429/429
(100 %)
1 diff
(99.8 %id)
AI301776 carcinoid, lung .e 1133 to 1394 264 to 3       262/264
(99 %)
0 diff
(100 %id)
AI309636 2 pooled tumors (clear cell type), Kidney .wn 805 to 1362 561 to 4   tiling clone,   558/561
(99 %)
0 diff
(100 %id)
AI342142 uterus .d 911 to 1354 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI366206 brain, meningioma .b 4814 to 5256 1 to 443     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
AI459511 brain, oligodendroglioma .d 533 to 860 1 to 328     Submitted on the opposite strand 328/328
(100 %)
3 diff
(99.1 %id)
AI276302 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 2008 to 2311 304 to 1       304/304
(100 %)
0 diff
(100 %id)
AI361248 brain, glioblastoma (pooled) .d 846 to 1352 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
AI431902 Kidney .wn 805 to 1360 566 to 11   AAA   556/556
(100 %)
2 diff
(99.7 %id)
AI453265 adenocarcinoma, Pancreas .e 1133 to 1395 265 to 3       263/265
(99 %)
0 diff
(100 %id)
AI589509 anaplastic oligodendroglioma, brain .d 906 to 1353 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AI569763 anaplastic oligodendroglioma, brain .c 1286 to 1586 301 to 1       301/301
(100 %)
0 diff
(100 %id)
AI569285 anaplastic oligodendroglioma, brain .wn 805 to 1343 556 to 18   AAA   539/539
(100 %)
4 diff
(99.3 %id)
AI799638 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 908 to 1352 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
AI538588 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .wn 916 to 1359 482 to 38   AAA   445/445
(100 %)
25 diff
(94.4 %id)
AI916462 adenocarcinoma, Pancreas .d 921 to 1352 447 to 16   AAA   432/432
(100 %)
0 diff
(100 %id)
AI700936 Kidney .wn 1110 to 1344 236 to 2       235/236
(99 %)
0 diff
(100 %id)
AI674713 pooled .d 902 to 1353 457 to 5       453/457
(99 %)
1 diff
(99.8 %id)
AI720273 colon .c 1242 to 1586 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AI740858 pooled .wn 840 to 1358 536 to 21   AAA   516/527
(97 %)
8 diff
(98.5 %id)
AI865534 normal prostate, Prostate .f 1961 to 2311 353 to 2       352/359
(98 %)
0 diff
(100 %id)
AI860591 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 909 to 1354 448 to 3       446/448
(99 %)
0 diff
(100 %id)
AI890501 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vd 16 to 432 1 to 418     Submitted on the opposite strand 418/418
(100 %)
2 diff
(99.6 %id)
AI888935 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 899 to 1394 497 to 2       496/497
(99 %)
0 diff
(100 %id)
AI950102 2 pooled tumors (clear cell type), Kidney .wn 1064 to 1349 290 to 5       286/290
(98 %)
0 diff
(100 %id)
AI971150 Prostate .c 1286 to 1588 303 to 1       303/303
(100 %)
3 diff
(99.1 %id)
AI991302 colon, colonic mucosa from 3 patients with Crohn'sdisease .vz 334 to 798 469 to 1   tiling clone,   465/469
(99 %)
0 diff
(100 %id)
AW008080 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 957 to 1395 454 to 16   AAA   439/439
(100 %)
5 diff
(98.9 %id)
AI955271 brain, four pooled pituitary adenomas .d 863 to 1354 509 to 18   AAA   492/492
(100 %)
1 diff
(99.8 %id)
AI954156 normal epithelium, ovary .d 908 to 1354 458 to 12   AAA   447/447
(100 %)
0 diff
(100 %id)
AW197006 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .f 1837 to 2308 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
AW084809 esophagus, squamous cell carcinoma .wn 1706 to 1952 269 to 23   AAA   247/247
(100 %)
5 diff
(98.0 %id)
AW168690 bowel (skin primary), metastatic melanoma to bowel .e 1130 to 1395 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
AW173463 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 880 to 1354 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AW189362 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 978 to 1358 382 to 4       379/382
(99 %)
1 diff
(99.8 %id)
AW512961 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vz 311 to 798 496 to 9       488/496
(98 %)
0 diff
(100 %id)
AW294963   .wn 959 to 1348 407 to 18   AAA   390/400
(97 %)
0 diff
(100 %id)
AW439468 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1027 to 1395 375 to 9       367/375
(97 %)
0 diff
(100 %id)
AW304159 lung, two pooled squamous cell carcinomas .d 906 to 1354 450 to 2       449/450
(99 %)
0 diff
(100 %id)
AW571757 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 775 to 1354 589 to 10       580/589
(98 %)
9 diff
(98.5 %id)
AW469951 2 pooled tumors (clear cell type), Kidney .wn 842 to 1144 303 to 1       303/316
(95 %)
15 diff
(95.3 %id)
AW440397 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 887 to 1353 470 to 3       468/470
(99 %)
0 diff
(100 %id)
AW613282 2 pooled high-grade transitional celltumors, genitourinary tract .f 1830 to 2309 485 to 6       480/485
(98 %)
0 diff
(100 %id)
AW613831 2 pooled high-grade transitional celltumors, genitourinary tract .f 1992 to 2311 320 to 1       320/320
(100 %)
0 diff
(100 %id)
AW630098 2 pooled high-grade transitional celltumors, genitourinary tract .f 567 to 686 1 to 120       120/120
(100 %)
0 diff
(100 %id)
BE208345 adenocarcinoma cell line, ovary .i 872 to 1372 511 to 11   AAA   501/502
(99 %)
0 diff
(100 %id)
BE208716 adenocarcinoma cell line, ovary .i 37 to 484 1 to 448       448/448
(100 %)
0 diff
(100 %id)
AW407016 lymph .c 667 to 982 8 to 323       316/323
(97 %)
6 diff
(98.2 %id)
CF140204 CNCAP(3)T-225 cell line, Prostate .f 531 to 1105 8 to 582       575/582
(98 %)
6 diff
(99.0 %id)
AW873725 adrenal gland, neuroblastoma .wn 1062 to 1361 300 to 1       300/300
(100 %)
0 diff
(100 %id)
BE047483 ovary, serous papillary tumor .e 942 to 1395 462 to 9       454/462
(98 %)
0 diff
(100 %id)
BE272021 adenocarcinoma cell line, ovary .c 661 to 1198 1 to 553       550/553
(99 %)
21 diff
(96.3 %id)
CB054867 brain, glioblastoma (pooled) .c 1198 to 1588 425 to 35   fully sequenced, AAA   391/391
(100 %)
0 diff
(100 %id)
CB054868 brain, glioblastoma (pooled) .c 667 to 1251 10 to 594   fully sequenced,   585/594
(98 %)
9 diff
(98.5 %id)
BE254446 eye, retinoblastoma .a 683 to 1165 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BF060999 pooled .wn 814 to 1362 553 to 5       549/553
(99 %)
0 diff
(100 %id)
BE540817 cervix .d 918 to 1350 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
BE540517 cervix .wm 1 to 491 1 to 490 L96W E97R T98H tiling clone,   757/888
(85 %)
22 diff
(97.6 %id)
BE548061 cervical carcinoma cell line, cervix .wg 94 to 808 1 to 709 P79L E80R V81S Y82T D83T ...     709/856
(82 %)
21 diff
(97.6 %id)
BE545360 cervical carcinoma cell line, cervix .c 690 to 1396 1 to 701       701/936
(74 %)
17 diff
(98.2 %id)
BE273453 Kidney, renal cell adenocarcinoma .wf 1 to 797 1 to 794 exact tiling clone,   794/796
(99 %)
6 diff
(99.3 %id)
BE297898 muscle, rhabdomyosarcoma .d 362 to 951 31 to 635       605/635
(95 %)
19 diff
(97.1 %id)
BE266212 lung, small cell carcinoma .d 419 to 1055 1 to 648       648/648
(100 %)
16 diff
(97.6 %id)
BE265087 lung, small cell carcinoma .d 419 to 1059 1 to 641       641/643
(99 %)
3 diff
(99.6 %id)
BE270463 Burkitt lymphoma, lymph .f 542 to 1189 26 to 672       647/673
(96 %)
7 diff
(99.0 %id)
BE277575 melanotic melanoma, skin .c 686 to 1199 46 to 559       514/559
(91 %)
6 diff
(99.0 %id)
BE379413 endometrium, adenocarcinoma cell line, uterus .e 412 to 1203 44 to 834       791/845
(93 %)
9 diff
(99.0 %id)
BE615926 adenocarcinoma, Pancreas .a 680 to 1564 1 to 882       882/919
(95 %)
42 diff
(95.5 %id)
BE397375 Burkitt lymphoma, lymph .f 542 to 1338 18 to 806       789/870
(90 %)
20 diff
(97.8 %id)
BE392755 endometrium, adenocarcinoma cell line, uterus .d 419 to 1079 1 to 659       659/660
(99 %)
12 diff
(98.2 %id)
BE383225 brain, neuroblastoma .d 723 to 1354 1 to 630   AAA   630/630
(100 %)
2 diff
(99.7 %id)
BE383182 brain, neuroblastoma .d 388 to 1064 1 to 672       672/726
(92 %)
6 diff
(99.2 %id)
BE408431 choriocarcinoma, placenta .d 420 to 997 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BE393756 endometrium, adenocarcinoma cell line, uterus .a 689 to 1329 1 to 642       642/679
(94 %)
7 diff
(99.0 %id)
BE736254 adenocarcinoma, Pancreas .d 548 to 1335 1 to 779       779/781
(99 %)
20 diff
(97.5 %id)
BE562309 Burkitt lymphoma, lymph .ve 392 to 1272 30 to 901 K180T     872/902
(96 %)
32 diff
(96.5 %id)
BE561699 Burkitt lymphoma, lymph .ve 394 to 1229 38 to 867 S39P T40H S41P Q42K E43R ...     830/931
(89 %)
20 diff
(97.9 %id)
BE728399 melanotic melanoma, skin .wa 58 to 847 1 to 762 C36A S37R A38L S39Q T40S ... tiling clone, AAA   767/892
(85 %)
46 diff
(94.9 %id)
BE747566 adenocarcinoma cell line, ovary .i 1 to 825 35 to 851   tiling clone,   817/1018
(80 %)
23 diff
(97.8 %id)
BE779691 eye, retinoblastoma .f 571 to 1227 1 to 664       664/721
(92 %)
14 diff
(98.1 %id)
BE783778 eye, retinoblastoma .c 662 to 1361 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
BE909684 epithelioid carcinoma, Pancreas .d 991 to 1349 1 to 359       359/359
(100 %)
2 diff
(99.5 %id)
BE889617 leiomyosarcoma, uterus .a 736 to 1531 1 to 794       794/829
(95 %)
18 diff
(97.9 %id)
BE888328 leiomyosarcoma, uterus .a 688 to 1348 1 to 656       656/656
(100 %)
7 diff
(99.0 %id)
BE896812 melanotic melanoma, skin .d 418 to 873 1 to 439       439/617
(71 %)
9 diff
(98.6 %id)
BE898118 melanotic melanoma, skin .d 785 to 1351 1 to 580       580/580
(100 %)
17 diff
(97.1 %id)
BE897853 melanotic melanoma, skin .d 785 to 1348 1 to 564       564/566
(99 %)
1 diff
(99.9 %id)
BE743817 adenocarcinoma cell line, ovary .wo 28 to 628 1 to 607       607/808
(75 %)
17 diff
(97.9 %id)
BE790832 lung, small cell carcinoma .c 657 to 1491 1 to 834       834/836
(99 %)
19 diff
(97.8 %id)
BE794181 lung, small cell carcinoma .d 419 to 1292 1 to 867       867/869
(99 %)
25 diff
(97.2 %id)
BC009181 Skin, melanotic melanoma. .wg 1 to 1619 9 to 1627 exact tiling clone, available from MGC, AAA   1619/1619
(100 %)
1 diff
(100.0 %id)
BF026010 melanotic melanoma, skin .wg 21 to 802 1 to 773 R18G S19A I20S L22S R23A ... available from MGC,   773/774
(99 %)
20 diff
(97.5 %id)
BE900397 choriocarcinoma, placenta .d 421 to 1122 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
BF125058 melanotic melanoma, skin .c 699 to 1298 1 to 607       607/946
(64 %)
19 diff
(98.0 %id)
BF185065 bone marrow, from chronic myelogenous leukemia .f 552 to 1160 1 to 617       615/1047
(58 %)
23 diff
(97.9 %id)
BF237967 leiomyosarcoma cell line, uterus .d 385 to 940 1 to 570       570/1116
(51 %)
33 diff
(97.1 %id)
BF204494 muscle, rhabdomyosarcoma .d 367 to 995 1 to 631       631/644
(97 %)
27 diff
(95.9 %id)
BF308812 muscle, rhabdomyosarcoma .u 1 to 730 3 to 735       735/928
(79 %)
46 diff
(95.1 %id)
BG060159 brain, glioblastoma without EGFR amplification .f 1835 to 2311 478 to 2       477/478
(99 %)
0 diff
(100 %id)
BG059621 brain, glioblastoma without EGFR amplification .d 918 to 1354 437 to 1       437/437
(100 %)
0 diff
(100 %id)
BF347460 anaplastic oligodendroglioma with 1p/19qloss, brain .vk 23 to 849 1 to 829   tiling clone,   829/859
(96 %)
31 diff
(96.4 %id)
BF338026 brain, glioblastoma with EGFR amplification .c 803 to 1582 1 to 783       783/976
(80 %)
22 diff
(97.8 %id)
BF339114 brain, glioblastoma with EGFR amplification .vd 17 to 783 1 to 762 K98T R99E K100E K101E L102A ...     762/1102
(69 %)
13 diff
(98.9 %id)
BF339355 brain, glioblastoma with EGFR amplification .g 869 to 1495 1 to 629       629/629
(100 %)
11 diff
(98.3 %id)
BF525431 brain, glioblastoma with EGFR amplification .d 823 to 1354 1 to 533   AAA   533/533
(100 %)
2 diff
(99.7 %id)
BF685927 leiomyosarcoma cell line, uterus .l 1 to 579 1 to 579   tiling clone,   579/909
(63 %)
2 diff
(99.8 %id)
BF971719 leiomyosarcoma cell line, uterus .u 24 to 747 1 to 730   tiling clone,   730/939
(77 %)
18 diff
(98.1 %id)
BF973904 leiomyosarcoma cell line, uterus .e 1215 to 1393 1 to 179   AAA   179/179
(100 %)
0 diff
(100 %id)
BF793094 adrenal cortex carcinoma, cell line, adrenal gland .d 710 to 1355 1 to 644       644/1118
(57 %)
4 diff
(99.7 %id)
BF969828 adrenal cortex carcinoma, cell line, adrenal gland .d 589 to 1313 1 to 752       725/1222
(59 %)
30 diff
(97.6 %id)
BG025384 lymph, lymphoma, cell line .a 661 to 1354 1 to 696       696/840
(82 %)
16 diff
(98.1 %id)
BG110393 Bone, osteosarcoma, cell line .d 765 to 1354 1 to 590   AAA   590/590
(100 %)
0 diff
(100 %id)
BG109619 Bone, osteosarcoma, cell line .c 644 to 1298 1 to 656       656/664
(98 %)
3 diff
(99.6 %id)
BG110613 Bone, osteosarcoma, cell line .c 743 to 1439 1 to 695       695/696
(99 %)
5 diff
(99.3 %id)
BG111381 Bone, osteosarcoma, cell line .d 592 to 1128 1 to 542       542/1344
(40 %)
8 diff
(99.5 %id)
BG113817 Bone, osteosarcoma, cell line .vd 80 to 876 1 to 803 K94N K95E K96E K97E K98E ...     801/926
(86 %)
52 diff
(94.4 %id)
BF967340 brain, hypothalamus .d 363 to 1137 1 to 779       779/860
(90 %)
25 diff
(97.1 %id)
BG105878 lymph, lymphoma, cell line .a 643 to 1352 1 to 711       711/840
(84 %)
3 diff
(99.7 %id)
BG034721 breast, mammary adenocarcinoma, cell line .d 391 to 1128 1 to 737       737/751
(98 %)
5 diff
(99.4 %id)
BG117300 adenocarcinoma, cell line, Liver .vd 22 to 782 9 to 757 R146E I147S Q148R A149H M150E ...     750/840
(89 %)
25 diff
(97.1 %id)
BG167559 hypernephroma, cell line, Kidney .c 668 to 1362 1 to 694       692/939
(73 %)
8 diff
(99.2 %id)
BG289377 bladder, transitional cell papilloma, cell line .e 1133 to 1395 1 to 262   AAA   262/262
(100 %)
1 diff
(99.7 %id)
BG393388 embryonal carcinoma, cell line, testis .u 24 to 810 1 to 779   tiling clone,   779/779
(100 %)
16 diff
(98.0 %id)
BG397649 B-cells, primary B-cells from tonsils (cell line) .f 668 to 1558 1 to 885       885/939
(94 %)
24 diff
(97.5 %id)
BG470495 eye, retinoblastoma .a 663 to 1495 1 to 838       838/839
(99 %)
41 diff
(95.2 %id)
BG475764 melanotic melanoma, skin .wg 1 to 402 1 to 403       403/897
(44 %)
4 diff
(99.6 %id)
BG469116 adenocarcinoma cell line, colon .l 237 to 684 1 to 452       452/830
(54 %)
10 diff
(98.8 %id)
BG474240 eye, retinoblastoma .c 1 to 776 1 to 776       776/778
(99 %)
17 diff
(97.9 %id)
BG474570 eye, retinoblastoma .d 390 to 961 1 to 576       576/576
(100 %)
10 diff
(98.3 %id)
BG542905 lung .c 621 to 704 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
BG574649 breast, mammary adenocarcinoma, cell line .c 785 to 1587 1 to 809       807/828
(97 %)
12 diff
(98.6 %id)
BG569916 lung .wa 19 to 141 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
BG774877 carcinoma, cell line, Prostate .i 22 to 650 1 to 628   fully sequenced,   628/628
(100 %)
4 diff
(99.4 %id)
BG775492 carcinoma, cell line, Prostate .i 589 to 1320 737 to 1   fully sequenced,   737/737
(100 %)
9 diff
(98.8 %id)
BC015605 Brain, neuroblastoma .vr 2 to 1696 1 to 1695 exact tiling clone, available from MGC, AAA   1695/1695
(100 %)
2 diff
(99.9 %id)
BG682871 brain, neuroblastoma, cell line .vr 1 to 694 1 to 697   tiling clone, available from MGC,   697/708
(98 %)
8 diff
(98.9 %id)
BG683585 brain, neuroblastoma, cell line .wg 870 to 1552 708 to 23   available from MGC,   686/708
(96 %)
4 diff
(99.5 %id)
BG707080 brain, hypothalamus .wa 10 to 766 1 to 758 K109N A110G E111G A112S Q113T ... tiling clone,   758/758
(100 %)
10 diff
(98.7 %id)
BG706697 brain, hypothalamus .wa 10 to 611 1 to 602   tiling clone,   602/604
(99 %)
8 diff
(98.7 %id)
BG709373 brain, hypothalamus .d 857 to 1354 1 to 497   AAA   497/497
(100 %)
4 diff
(99.2 %id)
BG716044 brain, hypothalamus .wa 10 to 716 1 to 725 K8*     725/725
(100 %)
32 diff
(95.6 %id)
BG704117 brain, hippocampus .vd 2 to 646 1 to 646       646/649
(99 %)
6 diff
(99.1 %id)
BG721722 testis .vz 2 to 789 1 to 787 exact tiling clone,   787/787
(100 %)
13 diff
(98.4 %id)
BG748444 eye, normal pigmented retinal epithelium .c 652 to 1361 1 to 716       716/717
(99 %)
11 diff
(98.5 %id)
BG743998 blood, natural killer cells, cell line .wo 162 to 653 1 to 493   fully sequenced,   493/493
(100 %)
3 diff
(99.4 %id)
BG744662 blood, natural killer cells, cell line .wo 592 to 1286 695 to 3 L108W E109R V110W E111S H112T ... tiling clone, fully sequenced,   693/695
(99 %)
2 diff
(99.8 %id)
BG745397 Spleen .wb 1 to 367 1 to 368   tiling clone, fully sequenced, AAA   368/368
(100 %)
4 diff
(99.0 %id)
BG746217 Spleen .wb 337 to 809 473 to 3   tiling clone, fully sequenced,   471/473
(99 %)
0 diff
(100 %id)
BG765065 melanotic melanoma, high MDR (cell line), skin .vj 1 to 625 6 to 635 K128E K129G K131G K132R L133G ... tiling clone,   635/746
(85 %)
24 diff
(96.8 %id)
BG751373 eye, normal pigmented retinal epithelium .vz 4 to 735 1 to 740 K96N K97E K98E K100G K101R ... tiling clone,   740/898
(82 %)
16 diff
(98.3 %id)
BG751950 eye, normal pigmented retinal epithelium .d 709 to 1354 1 to 646       646/666
(96 %)
1 diff
(99.9 %id)
BG752902 eye, normal pigmented retinal epithelium .a 781 to 1533 1 to 754       754/754
(100 %)
4 diff
(99.5 %id)
BG819260 anaplastic oligodendroglioma with 1p/19qloss, brain .a 643 to 1369 12 to 738       727/738
(98 %)
13 diff
(98.3 %id)
BG912136 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3768 to 4185 1 to 418       418/418
(100 %)
12 diff
(97.2 %id)
BG910912 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2221 to 2724 314 to 827       514/833
(61 %)
30 diff
(96.4 %id)
BI090609 cervix .e 826 to 1394 1 to 569       569/587
(96 %)
2 diff
(99.7 %id)
BI114111 muscle, rhabdomyosarcoma .d 367 to 755 1 to 392       392/1021
(38 %)
11 diff
(99.0 %id)
BI712095 Pancreas, Purified pancreatic islet .vz 408 to 798 396 to 4   fully sequenced,   393/396
(99 %)
0 diff
(100 %id)
BI713047 Pancreas, Purified pancreatic islet .vz 42 to 469 1 to 432   fully sequenced,   428/428
(100 %)
0 diff
(100 %id)
BI252119 hepatocellular carcinoma, cell line, Liver .q 1 to 432 1 to 434   tiling clone,   434/803
(54 %)
11 diff
(98.7 %id)
BI227310 Burkitt lymphoma, lymph .ve 392 to 935 46 to 595       550/597
(92 %)
31 diff
(94.9 %id)
BI225409 Burkitt lymphoma, lymph .c 688 to 1436 1 to 759       759/759
(100 %)
32 diff
(95.8 %id)
BI259538 cervical carcinoma cell line, cervix .a 658 to 1457 1 to 803       803/964
(83 %)
6 diff
(99.4 %id)
BC033857 Cervix, carcinoma .wl 1 to 1480 12 to 1491 exact tiling clone, available from MGC, AAA   1480/1480
(100 %)
1 diff
(100.0 %id)
BI258499 cervical carcinoma cell line, cervix .wl 1 to 835 1 to 837 L97* available from MGC,   837/838
(99 %)
16 diff
(98.1 %id)
BI257265 cervical carcinoma cell line, cervix .u 40 to 834 24 to 823 S85I S86L S87L S88F S89L ... tiling clone,   800/827
(96 %)
46 diff
(94.5 %id)
BI520720 brain, medulla .e 1257 to 1318 62 to 1       62/62
(100 %)
0 diff
(100 %id)
BI825248 brain, medulla .f 572 to 1558 1 to 980       980/1044
(93 %)
32 diff
(97.0 %id)
BI830872 brain, medulla .f 563 to 1373 1 to 815       815/815
(100 %)
7 diff
(99.2 %id)
BI822879 pooled brain, lung, testis .wp 483 to 1225 1 to 745   tiling clone, AAA   745/745
(100 %)
7 diff
(99.1 %id)
BI761306 pooled colon, kidney, stomach .c 733 to 1479 1 to 748       748/751
(99 %)
6 diff
(99.3 %id)
BI762747 pooled colon, kidney, stomach .f 539 to 1426 1 to 897       897/919
(97 %)
20 diff
(97.9 %id)
BI758182 brain .k 23 to 918 1 to 894       894/900
(99 %)
21 diff
(97.7 %id)
BI766561 pooled lung and spleen .vx 4 to 901 1 to 905 exact tiling clone,   905/909
(99 %)
25 diff
(97.3 %id)
BI519850 leukocyte .g 1101 to 1743 676 to 6       671/821
(81 %)
0 diff
(100 %id)
BI911669 leukocyte .f 526 to 1136 33 to 668       608/889
(68 %)
36 diff
(96.0 %id)
BI909652 leukocyte .vk 18 to 821 1 to 806   tiling clone,   806/806
(100 %)
6 diff
(99.3 %id)
BI910394 leukocyte .vl 1700 to 2494 1 to 795   tiling clone,   795/796
(99 %)
5 diff
(99.4 %id)
BI907933 leukocyte .f 580 to 1240 1 to 684       655/829
(79 %)
51 diff
(93.9 %id)
BI908558 leukocyte .g 37 to 729 1 to 693       693/693
(100 %)
8 diff
(98.9 %id)
BI910789 leukocyte .vm 1 to 809 1 to 805 P4T L137* tiling clone,   805/805
(100 %)
6 diff
(99.3 %id)
BI838334 pooled pancreas and spleen .d 385 to 1221 1 to 834       834/834
(100 %)
8 diff
(99.1 %id)
BI915979 brain .b 4208 to 5039 1 to 842       842/854
(98 %)
50 diff
(94.2 %id)
BI915561 brain .k 8 to 770 1 to 766       766/766
(100 %)
10 diff
(98.7 %id)
BI915779 brain .b 3892 to 4187 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
BI560794 testis .vs 2 to 821 1 to 827 K118R E119R K120R A121R E122K ...     827/858
(96 %)
16 diff
(98.2 %id)
BI599566 brain, hypothalamus .c 640 to 1134 1 to 494       494/494
(100 %)
6 diff
(98.8 %id)
BI667920 brain, hypothalamus .wa 10 to 832 1 to 819 K98T tiling clone,   819/820
(99 %)
22 diff
(97.4 %id)
BI670145 brain, hypothalamus .vc 1 to 630 1 to 630   tiling clone,   630/630
(100 %)
6 diff
(99.1 %id)
BI670459 brain, hypothalamus .wa 10 to 770 1 to 761 L168V L169A P170S tiling clone,   761/761
(100 %)
11 diff
(98.6 %id)
BI871123 adenocarcinoma, cell line, Liver .o 1 to 887 1 to 897 A44R P45L Q46S S47L G48E ... tiling clone,   893/897
(99 %)
29 diff
(96.8 %id)
BM050318 eye, normal pigmented retinal epithelium .u 45 to 440 1 to 396       396/830
(47 %)
8 diff
(99.1 %id)
BM050791 eye, normal pigmented retinal epithelium .c 652 to 1485 1 to 828       828/920
(90 %)
91 diff
(90.2 %id)
BM051282 eye, normal pigmented retinal epithelium .d 391 to 800 1 to 414       414/901
(45 %)
17 diff
(98.2 %id)
BM020074 astrocytoma grade IV, cell line, brain .f 575 to 1395 1 to 823       823/824
(99 %)
8 diff
(99.1 %id)
BM560742 astrocytoma grade IV, cell line, brain .f 576 to 1347 1 to 773       773/1069
(72 %)
18 diff
(98.4 %id)
BM043071 carcinoma, cell line, Prostate .d 390 to 995 1 to 611       611/756
(80 %)
12 diff
(98.5 %id)
BM909804 astrocytoma grade IV, cell line, brain .vi 1 to 799 1 to 805 K166X E167G E168G W169V D170G ... tiling clone,   805/1092
(73 %)
9 diff
(99.2 %id)
BM009680 amelanotic melanoma, cell line, skin .d 731 to 1354 1 to 622   AAA   622/622
(100 %)
5 diff
(99.2 %id)
BM044979 carcinoma, cell line, Prostate .f 575 to 1513 1 to 930       930/932
(99 %)
19 diff
(98.0 %id)
BM910358 astrocytoma grade IV, cell line, brain .f 577 to 1447 1 to 884       883/1052
(83 %)
19 diff
(98.2 %id)
BM810761 amelanotic melanoma, cell line, skin .d 693 to 1354 1 to 672       672/1143
(58 %)
30 diff
(97.4 %id)
BM559502 amelanotic melanoma, cell line, skin .d 692 to 1354 1 to 663       663/1080
(61 %)
1 diff
(100.0 %id)
BM913678 astrocytoma grade IV, cell line, brain .f 559 to 864 1 to 306       306/707
(43 %)
1 diff
(99.9 %id)
BM904219 lymph, lymphoma, cell line .r 1 to 791 1 to 797 Q225R A226H T228Q A229P L230* tiling clone,   797/1048
(76 %)
17 diff
(98.4 %id)
BM457943 leiomyosarcoma, uterus .f 573 to 1085 1 to 513       513/1435
(35 %)
6 diff
(99.6 %id)
BM801366 duodenal adenocarcinoma, cell line, small intestine .i 150 to 858 1 to 715       715/1023
(69 %)
17 diff
(98.4 %id)
BM808167 ovary (pool of 3) .wg 12 to 725 12 to 725       714/1100
(64 %)
26 diff
(97.7 %id)
BM857759 insulinoma, Pancreas .e 1104 to 1393 9 to 298   AAA   290/298
(97 %)
6 diff
(98.0 %id)
BM546916 ovary (pool of 3) .d 760 to 1354 21 to 615       595/619
(96 %)
7 diff
(98.9 %id)
BM906806 ovary (pool of 3) .d 760 to 1354 13 to 608       596/635
(93 %)
8 diff
(98.8 %id)
BM552691 brain, medulla .wn 903 to 1360 1 to 458       458/531
(86 %)
1 diff
(99.9 %id)
BM560177 brain, medulla .vk 17 to 840 20 to 848   tiling clone,   829/1029
(80 %)
23 diff
(97.8 %id)
BM920456 pooled lung and spleen .f 550 to 1515 1 to 985       985/1118
(88 %)
30 diff
(97.4 %id)
BM920986 pooled brain, lung, testis .b 4437 to 4946 70 to 588       519/1367
(37 %)
26 diff
(98.1 %id)
BC071172 Blood, adult leukocytes .m 1 to 2190 1 to 2190 exact tiling clone, available from MGC, AAA   2190/2190
(100 %)
4 diff
(99.9 %id)
BM922728 leukocyte .m 2 to 997 1 to 1008   available from MGC,   1008/1019
(98 %)
31 diff
(97.0 %id)
BQ130497 insulinoma, Pancreas .d 536 to 1082 1 to 547     Submitted on the opposite strand 547/547
(100 %)
3 diff
(99.5 %id)
BQ130750 insulinoma, Pancreas .d 771 to 1339 576 to 8     Submitted on the opposite strand 569/576
(98 %)
4 diff
(99.4 %id)
BQ267691 insulinoma, Pancreas .d 813 to 1337 532 to 8     Submitted on the opposite strand 525/532
(98 %)
2 diff
(99.7 %id)
BQ272300 insulinoma, Pancreas .d 537 to 1082 1 to 546     Submitted on the opposite strand 546/546
(100 %)
1 diff
(99.9 %id)
BQ270597 insulinoma, Pancreas .c 804 to 1370 1 to 567     Submitted on the opposite strand 567/567
(100 %)
1 diff
(99.9 %id)
BQ270841 insulinoma, Pancreas .d 829 to 1328 507 to 8     Submitted on the opposite strand 500/507
(98 %)
0 diff
(100 %id)
BQ267393 insulinoma, Pancreas .d 537 to 1082 1 to 546     Submitted on the opposite strand 546/546
(100 %)
1 diff
(99.9 %id)
BQ270189 insulinoma, Pancreas .d 755 to 1347 594 to 2     Submitted on the opposite strand 593/594
(99 %)
0 diff
(100 %id)
BQ068904 brain, neuroblastoma, cell line .vr 3 to 805 1 to 812       812/988
(82 %)
9 diff
(99.1 %id)
BQ069107 brain, neuroblastoma, cell line .c 653 to 1508 21 to 875       855/1062
(80 %)
23 diff
(97.9 %id)
BQ278869 adenocarcinoma, cell line, breast .vz 391 to 796 1 to 406   AAA   406/406
(100 %)
1 diff
(99.8 %id)
BQ014311 Chondrosarcoma, Left Pubic Bone .g 1163 to 1801 655 to 17   tiling clone, AAA   639/639
(100 %)
0 diff
(100 %id)
BQ016450 lung, Metastatic Chondrosarcoma .d 906 to 1352 467 to 21       447/475
(94 %)
0 diff
(100 %id)
BQ018325 lung, Metastatic Chondrosarcoma .d 835 to 1354 536 to 17   AAA   520/520
(100 %)
0 diff
(100 %id)
BQ001689 lung, Metastatic Chondrosarcoma .d 737 to 1354 634 to 17   AAA   618/630
(98 %)
1 diff
(99.9 %id)
BQ065401 lymph, lymphoma, cell line .d 693 to 1352 1 to 660   AAA   660/660
(100 %)
1 diff
(99.9 %id)
BQ051835 blood, natural killer cells, cell line .t 3 to 772 1 to 771 F115L I116L E140D A152S I158M ... tiling clone,   771/1034
(74 %)
43 diff
(95.9 %id)
BQ051930 blood, natural killer cells, cell line .t 1 to 545 1 to 552   tiling clone,   552/1314
(42 %)
30 diff
(97.8 %id)
BQ053780 blood, natural killer cells, cell line .wo 165 to 1116 24 to 983   tiling clone,   960/983
(97 %)
29 diff
(97.1 %id)
BQ054027 blood, natural killer cells, cell line .wo 167 to 908 34 to 782       749/1125
(66 %)
21 diff
(98.2 %id)
BQ430962 large cell carcinoma, lung .d 502 to 1306 24 to 835       812/1109
(73 %)
30 diff
(97.3 %id)
BQ549324 insulinoma, Pancreas .c 804 to 1373 1 to 570     Submitted on the opposite strand 570/570
(100 %)
2 diff
(99.7 %id)
BQ581151 insulinoma, Pancreas .d 813 to 1354 565 to 24   AAA Submitted on the opposite strand 542/542
(100 %)
0 diff
(100 %id)
BC047676 Testis, embryonal carcinoma .vt 1 to 1464 1 to 1464 exact tiling clone, available from MGC, AAA   1464/1464
(100 %)
0 diff
(100 %id)
BQ232986 epithelioid carcinoma, Pancreas .c 663 to 1427 1 to 772       772/850
(90 %)
8 diff
(99.1 %id)
BQ226426 large cell carcinoma, lung .d 383 to 1233 1 to 857       857/868
(98 %)
17 diff
(98.1 %id)
BU162577 melanotic melanoma, cell line, skin .d 398 to 1147 1 to 760       760/902
(84 %)
22 diff
(97.6 %id)
BU197265 epidermoid carcinoma, cell line, salivary gland .f 579 to 1479 1 to 918       918/926
(99 %)
27 diff
(97.1 %id)
BU175071 epidermoid carcinoma, cell line, salivary gland .e 905 to 1395 21 to 511   tiling clone, AAA   491/511
(96 %)
6 diff
(98.9 %id)
BU163738 epidermoid carcinoma, cell line, salivary gland .f 579 to 1344 1 to 771       771/943
(81 %)
12 diff
(98.8 %id)
BU153708 epithelioid carcinoma, Pancreas .c 667 to 1427 1 to 764       764/913
(83 %)
11 diff
(98.8 %id)
BU949679 Pancreas, Purified pancreatic islet .vs 441 to 830 391 to 2   fully sequenced,   390/391
(99 %)
0 diff
(100 %id)
BU949967 Pancreas, Purified pancreatic islet .vs 3 to 502 1 to 504   fully sequenced,   500/500
(100 %)
0 diff
(100 %id)
BU948724 Pancreas, Purified pancreatic islet .d 964 to 1353 390 to 1   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
BU948976 Pancreas, Purified pancreatic islet .d 748 to 1025 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
BU787410 insulinoma, Pancreas .c 804 to 1395 1 to 592     Submitted on the opposite strand 592/592
(100 %)
1 diff
(99.9 %id)
BU787688 insulinoma, Pancreas .d 756 to 1328 580 to 8     Submitted on the opposite strand 573/580
(98 %)
0 diff
(100 %id)
BU786073 insulinoma, Pancreas .d 631 to 1209 41 to 619     Submitted on the opposite strand 579/619
(93 %)
6 diff
(99.1 %id)
BU947280 insulinoma, Pancreas .d 737 to 1358 626 to 5     Submitted on the opposite strand 622/626
(99 %)
1 diff
(99.9 %id)
BU951090 Pancreas, Purified pancreatic islet .d 465 to 961 1 to 497   fully sequenced,   497/497
(100 %)
0 diff
(100 %id)
BU952530 Pancreas, Purified pancreatic islet .d 931 to 1354 429 to 6   fully sequenced,   424/429
(98 %)
1 diff
(99.8 %id)
BU188353 melanotic melanoma, skin .d 391 to 1064 1 to 676       676/964
(70 %)
9 diff
(99.1 %id)
BQ426034 melanotic melanoma, skin .c 643 to 1427 1 to 795       795/942
(84 %)
20 diff
(97.9 %id)
BU191556 epidermoid carcinoma, cell line, salivary gland .f 579 to 1425 1 to 853       852/904
(94 %)
27 diff
(97.1 %id)
BQ670852 epidermoid carcinoma, cell line, salivary gland .d 764 to 1279 1 to 516       516/520
(99 %)
1 diff
(99.9 %id)
BQ671741 epidermoid carcinoma, cell line, salivary gland .e 911 to 1399 1 to 491       491/1148
(42 %)
6 diff
(99.5 %id)
BQ643520 hepatocellular carcinoma, cell line, Liver .q 3 to 801 1 to 806   tiling clone,   806/825
(97 %)
15 diff
(98.2 %id)
BQ653070 hepatocellular carcinoma, cell line, Liver .va 1 to 717 25 to 747 I173H R174P K175Q V176G V177G ... tiling clone,   728/1004
(72 %)
36 diff
(96.5 %id)
BQ670612 epidermoid carcinoma, cell line, salivary gland .f 579 to 1098 1 to 520       520/1157
(44 %)
5 diff
(99.6 %id)
BQ668608 epidermoid carcinoma, cell line, salivary gland .a 483 to 946 1 to 464       464/997
(46 %)
15 diff
(98.5 %id)
BQ647333 hepatocellular carcinoma, cell line, Liver .q 3 to 912 1 to 915   tiling clone,   915/917
(99 %)
22 diff
(97.7 %id)
BQ890325 eye, normal pigmented retinal epithelium .c 666 to 1298 1 to 633       633/975
(64 %)
15 diff
(98.5 %id)
BQ711564 Spleen .d 387 to 1193 1 to 818       818/981
(83 %)
27 diff
(97.3 %id)
BQ882613 Spleen .d 692 to 1354 1 to 663   AAA   663/663
(100 %)
1 diff
(99.9 %id)
BQ641858 eye, normal pigmented retinal epithelium .d 690 to 1352 1 to 663   AAA   663/663
(100 %)
4 diff
(99.4 %id)
BU501436 eye, normal pigmented retinal epithelium .c 707 to 1589 1 to 887   AAA   887/887
(100 %)
10 diff
(98.9 %id)
BU150659 brain, neuroblastoma, cell line .d 4 to 810 1 to 818       818/974
(83 %)
36 diff
(96.4 %id)
BQ918931 large cell carcinoma, lung .c 654 to 1508 1 to 857       857/907
(94 %)
6 diff
(99.4 %id)
BQ927494 carcinoma, cell line, Prostate .d 387 to 1281 1 to 912       912/943
(96 %)
41 diff
(95.7 %id)
BQ927874 carcinoma, cell line, Prostate .d 424 to 1064 1 to 645       645/970
(66 %)
10 diff
(99.0 %id)
BQ935674 carcinoma, cell line, Prostate .d 387 to 1277 1 to 895       895/935
(95 %)
22 diff
(97.7 %id)
BQ943601 carcinoma, cell line, Prostate .vc 164 to 1007 1 to 842 exact     842/927
(90 %)
10 diff
(99.0 %id)
BQ941529 large cell carcinoma, lung .c 777 to 1588 1 to 811   AAA   811/811
(100 %)
1 diff
(99.9 %id)
BU509220 leiomyosarcoma, uterus .wn 606 to 1419 1 to 825       825/871
(94 %)
21 diff
(97.6 %id)
BU526490 epidermoid carcinoma, cell line, lung .d 591 to 1354 9 to 772       764/952
(80 %)
6 diff
(99.4 %id)
BU526554 epidermoid carcinoma, cell line, lung .f 581 to 1493 9 to 922       914/922
(99 %)
9 diff
(99.1 %id)
BU542276 carcinoma, cell line, Prostate .i 25 to 822 1 to 807       807/896
(90 %)
14 diff
(98.5 %id)
BU552522 carcinoma, cell line, Prostate .vc 162 to 1056 1 to 903 exact tiling clone,   903/903
(100 %)
9 diff
(99.1 %id)
BU552615 carcinoma, cell line, Prostate .i 22 to 914 1 to 899   tiling clone,   899/902
(99 %)
8 diff
(99.2 %id)
BU553829 ovary, teratocarcinoma, cell line .d 382 to 1271 1 to 908       908/934
(97 %)
33 diff
(96.5 %id)
BU564691 mixed (pool of 40 RNAs) .d 871 to 1354 1 to 478       478/514
(92 %)
7 diff
(98.7 %id)
CA866709 Pancreas, Purified pancreatic islet .vs 43 to 572 1 to 530   fully sequenced,   530/530
(100 %)
0 diff
(100 %id)
CA866966 Pancreas, Purified pancreatic islet .vs 511 to 830 323 to 4   fully sequenced,   320/323
(99 %)
0 diff
(100 %id)
CA868051 Pancreas, Purified pancreatic islet .ve 333 to 847 1 to 515   fully sequenced,   515/515
(100 %)
0 diff
(100 %id)
CA868300 Pancreas, Purified pancreatic islet .ve 801 to 1309 512 to 4   tiling clone, fully sequenced,   509/512
(99 %)
0 diff
(100 %id)
BU858218 adenocarcinoma, cell line, breast .ve 228 to 905 31 to 714       684/929
(73 %)
20 diff
(97.9 %id)
CX870403 embryonic stem .s 1 to 669 1 to 669   tiling clone,   669/669
(100 %)
0 diff
(100 %id)
CX870960 embryonic stem .f 552 to 1314 1 to 763       763/763
(100 %)
0 diff
(100 %id)
DN602277 human embryonic stem cells .f 572 to 1365 20 to 813       794/813
(97 %)
6 diff
(99.3 %id)
CV807455 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .wo 26 to 737 1 to 712       712/712
(100 %)
0 diff
(100 %id)
CV805116 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vc 86 to 792 1 to 705       705/729
(96 %)
14 diff
(98.1 %id)
CV803535 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 660 to 1354 1 to 691       691/836
(82 %)
7 diff
(99.2 %id)
DR156255 human embryonic stem cells differentiated toan early endodermal cell type .h 344 to 1013 1 to 670   tiling clone,   670/670
(100 %)
0 diff
(100 %id)
CB594868 Blood, promyelocytic leukemia .f 579 to 1447 1 to 875       875/876
(99 %)
10 diff
(98.9 %id)
CB992528 placenta, pre-eclamptic placenta .a 644 to 1284 27 to 671       645/860
(75 %)
12 diff
(98.7 %id)
CB994415 placenta, pre-eclamptic placenta .vh 1 to 719 28 to 760 L162P Q163A P164A L165A M166D ... tiling clone,   733/848
(86 %)
31 diff
(96.4 %id)
CB994935 placenta, pre-eclamptic placenta .vh 1 to 614 28 to 642   tiling clone,   615/685
(89 %)
8 diff
(98.9 %id)
CB991294 placenta, pre-eclamptic placenta .vh 2 to 426 29 to 453       425/476
(89 %)
7 diff
(98.6 %id)
CB961420 placenta, pre-eclamptic placenta .a 644 to 1284 27 to 672       646/788
(81 %)
15 diff
(98.1 %id)
CF127647 Chondrosarcoma Lung Metastasis cell lines, lung .c 483 to 1192 1 to 710       710/710
(100 %)
3 diff
(99.6 %id)
DA617604   .f 613 to 1189 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
TI_57220773   .k 23 to 918 67 to 960       894/966
(92 %)
26 diff
(97.4 %id)
TI_57202076   .wn 597 to 1347 25 to 777 C183X A184C L185A T186H *187L AAA   753/777
(96 %)
12 diff
(98.5 %id)
TI_57147188   .c 725 to 1479 27 to 782       756/785
(96 %)
12 diff
(98.5 %id)
TI_57150410   .f 539 to 1426 68 to 964       897/986
(90 %)
25 diff
(97.5 %id)
TI_57177519   .vx 1 to 901 28 to 935 exact tiling clone,   908/939
(96 %)
31 diff
(96.7 %id)
TI_44459985   .g 1101 to 1743 676 to 6       671/821
(81 %)
0 diff
(100 %id)
TI_57233480   .f 526 to 1136 33 to 668       608/889
(68 %)
36 diff
(96.0 %id)
TI_57234888   .vk 18 to 821 34 to 839       806/839
(96 %)
12 diff
(98.6 %id)
TI_57235947   .vl 1700 to 2494 34 to 828       795/829
(95 %)
11 diff
(98.7 %id)
TI_57236322   .f 575 to 1240 28 to 716       660/861
(76 %)
54 diff
(93.8 %id)
TI_57237229   .g 33 to 729 27 to 724       698/724
(96 %)
14 diff
(98.1 %id)
TI_57237540   .vm 1 to 809 32 to 836 P4T L137*     805/836
(96 %)
11 diff
(98.7 %id)
TI_57170131   .f 571 to 1558 29 to 1009       981/1073
(91 %)
38 diff
(96.5 %id)
TI_57177366   .f 561 to 1373 62 to 878       817/878
(93 %)
15 diff
(98.3 %id)
TI_57162973   .d 385 to 1221 36 to 869       834/869
(95 %)
14 diff
(98.4 %id)
TI_57238830   .k 1 to 770 22 to 794   tiling clone,   773/794
(97 %)
16 diff
(98.0 %id)
TI_57238959   .b 4208 to 5039 32 to 873       842/885
(95 %)
50 diff
(94.4 %id)
TI_57243532   .b 3887 to 4809 28 to 961       934/1006
(92 %)
51 diff
(95.0 %id)
TI_45212992   .c 645 to 1245 85 to 684       600/684
(87 %)
7 diff
(99.0 %id)
TI_44349199   .vs 1 to 821 86 to 913 K118R E119R K120R A121R E122K ... tiling clone,   832/1059
(78 %)
22 diff
(98.0 %id)
TI_44343877   .wa 15 to 832 91 to 904 K98T     814/905
(89 %)
21 diff
(97.7 %id)
TI_44344592   .vc 1 to 716 80 to 795       720/795
(90 %)
11 diff
(98.7 %id)
TI_44345414   .wa 15 to 770 87 to 842 L168V L169A P170S     756/842
(89 %)
10 diff
(98.9 %id)
TI_57230334   .o 1 to 887 92 to 988 A44R P45L Q46S S47L G48E ...     893/897
(99 %)
29 diff
(96.8 %id)
TI_59384447   .d 731 to 1354 56 to 677   AAA   622/622
(100 %)
5 diff
(99.2 %id)
TI_59390853   .f 574 to 1395 95 to 918       824/825
(99 %)
8 diff
(99.1 %id)
BP279509   .f 1 to 563 1 to 564   tiling clone,   564/565
(99 %)
4 diff
(99.3 %id)
DA632297 Kidney .f 554 to 1138 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CB128843 Liver .vg 1 to 627 1 to 627   tiling clone,   627/627
(100 %)
2 diff
(99.7 %id)
CB116913 Liver .vg 1 to 527 1 to 527   tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
CB129995 Liver .vw 1 to 609 1 to 609 exact tiling clone,   609/609
(100 %)
0 diff
(100 %id)
CB145562 Liver .c 620 to 958 1 to 339       339/339
(100 %)
1 diff
(99.8 %id)
CB142899 Liver .f 556 to 1032 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
CB141858 Liver .c 636 to 962 1 to 327       327/327
(100 %)
2 diff
(99.4 %id)
CB144421 Liver .c 619 to 1084 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BP297107   .f 620 to 1192 1 to 573       573/581
(98 %)
3 diff
(99.5 %id)
BP299927   .f 553 to 1133 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CD580469 brain .p 1 to 850 1 to 852 R12C A36S G129V A258T A263G ... tiling clone,   852/909
(93 %)
12 diff
(98.7 %id)
CD579492 brain .d 363 to 1039 1 to 675       675/869
(77 %)
12 diff
(98.7 %id)
CD579510 brain .d 363 to 1039 1 to 675       675/869
(77 %)
12 diff
(98.7 %id)
DR421759 eye, Pterygium .a 676 to 1314 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
DA665818   .vy 1 to 514 2 to 515 L157I tiling clone, capped   514/514
(100 %)
2 diff
(99.7 %id)
EB386948 eye, optic nerve .a 641 to 1455 1 to 815       815/815
(100 %)
0 diff
(100 %id)
DA678566   .f 552 to 1118 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AI752542 Bone, Hip .d 400 to 738 9 to 347       339/347
(97 %)
0 diff
(100 %id)
NM_016638.2   .c 275 to 1595 1 to 1321   RefSeq,   1321/1321
(100 %)
3 diff
(99.8 %id)
NM_018694.2   .a 274 to 1651 1 to 1378   RefSeq,   1378/1378
(100 %)
3 diff
(99.8 %id)
NM_024623.1   .n 1 to 2079 2 to 2080 exact RefSeq,   2080/2080
(100 %)
3 diff
(99.9 %id)
NM_001002251.1   .d 8 to 1361 1 to 1354   RefSeq,   1354/1354
(100 %)
3 diff
(99.8 %id)
NM_001002252.1   .e 1 to 1402 1 to 1402 exact RefSeq,   1402/1402
(100 %)
3 diff
(99.8 %id)
DB367959.
matches multiple genes
  .d 873 to 1358 486 to 1     also hits gene DPYSL2 486/531
(91 %)
3 diff
(99.5 %id)
DA749959   .wg 57 to 619 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AU136439 placenta .n 1 to 734 2 to 742   capped   739/798
(92 %)
14 diff
(98.3 %id)
AU156723 placenta .n 1534 to 2079 545 to 1       545/545
(100 %)
17 diff
(96.9 %id)
BP324148 Pancreas .c 645 to 1176 1 to 531       531/583
(91 %)
7 diff
(98.8 %id)
BP330828 rectum .f 549 to 1130 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
CR991128 T-Lymphocytes .wi 1 to 543 1 to 545 R4S R5K R6V G7R A8G ... tiling clone,   545/587
(92 %)
6 diff
(99.0 %id)
CR980315 T-Lymphocytes .c 766 to 1586 1 to 821   AAA   821/821
(100 %)
2 diff
(99.8 %id)
CR975683 T-Lymphocytes .c 665 to 1195 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CR985644 T-Lymphocytes .f 576 to 743 1 to 169       169/170
(99 %)
5 diff
(97.1 %id)
CR988772 T-Lymphocytes .c 667 to 1391 18 to 746       729/747
(97 %)
11 diff
(98.6 %id)
CR988345 T-Lymphocytes .u 46 to 663 1 to 618   tiling clone,   618/618
(100 %)
0 diff
(100 %id)
CR981251 T-Lymphocytes .l 214 to 820 1 to 607       607/610
(99 %)
1 diff
(99.9 %id)
CR990778 T-Lymphocytes .k 29 to 472 1 to 446       446/448
(99 %)
12 diff
(97.4 %id)
CR988774 T-Lymphocytes .c 635 to 1229 1 to 594       594/601
(98 %)
6 diff
(99.1 %id)
CT003672 T-Lymphocytes .u 1 to 812 6 to 812 K94R S140I A141S G142W E143G ... tiling clone,   812/825
(98 %)
9 diff
(99.0 %id)
CT003609 T-Lymphocytes .a 645 to 1153 60 to 568       509/571
(89 %)
7 diff
(98.8 %id)
CR994937 T-Lymphocytes .wj -8 to 707 1 to 716 exact tiling clone,   716/716
(100 %)
1 diff
(99.9 %id)
CR983970 T-Lymphocytes .k 25 to 674 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
BM790492 Ascites, stomach .b 5389 to 5953 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BM793735 Ascites, stomach .wh 1 to 541 1 to 541 Q125H tiling clone,   541/541
(100 %)
1 diff
(99.9 %id)
BM793598 Ascites, stomach .d 785 to 1243 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BM793930 Ascites, stomach .we 186 to 871 1 to 686   tiling clone,   686/686
(100 %)
1 diff
(99.9 %id)
BM793504 Ascites, stomach .d 753 to 1345 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM824758 Ascites, stomach .wf 591 to 1073 1 to 483   tiling clone,   483/483
(100 %)
0 diff
(100 %id)
F27927 pectoral muscle (after mastectomy) .c 1223 to 1586 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
F27933 pectoral muscle (after mastectomy) .c 1220 to 1586 1 to 366   AAA   366/366
(100 %)
4 diff
(99.0 %id)
F25803 pectoral muscle (after mastectomy) .d 990 to 1270 1 to 281       281/281
(100 %)
0 diff
(100 %id)
F31334 pectoral muscle (after mastectomy) .d 872 to 1154 1 to 282       282/282
(100 %)
2 diff
(99.3 %id)
TI_1948084345   .b 5310 to 5833 653 to 126       528/1165
(45 %)
29 diff
(97.6 %id)
TI_1948084899   .e 489 to 1077 713 to 125       589/1482
(39 %)
28 diff
(98.2 %id)
F36692 pectoral muscle (after mastectomy) .c 1223 to 1576 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
DC386083   .b 28 to 487 1 to 462       462/462
(100 %)
2 diff
(99.6 %id)
BP343061 stomach mucosa .wo 16 to 597 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA967054 stomach .wn 1 to 569 3 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BP351012   .vu 8 to 590 1 to 583 exact     583/583
(100 %)
0 diff
(100 %id)
DN995613 breast cancer, Mammary gland (cancer tissue) .e 958 to 1393 1 to 436   AAA   436/436
(100 %)
5 diff
(98.9 %id)
DN992667 brain, whole brain .vc 147 to 692 1 to 547       547/547
(100 %)
10 diff
(98.2 %id)
DR004628 placenta .wq 35 to 640 1 to 605 exact     605/605
(100 %)
6 diff
(99.1 %id)
DN994077 brain, whole brain .s 256 to 685 9 to 438       430/438
(98 %)
6 diff
(98.7 %id)
BM150829 leukopheresis .b 3811 to 4256 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BM152832 leukopheresis .m 717 to 1129 12 to 424       413/424
(97 %)
7 diff
(98.4 %id)
BE246616 leukopheresis .m 719 to 1109 35 to 427       393/427
(92 %)
15 diff
(96.5 %id)
BM151276 leukopheresis .b 3911 to 4256 346 to 1       346/346
(100 %)
14 diff
(96.0 %id)
DB009535 colon, tumor tissue .b 416 to 826 2 to 412   tiling clone, capped   411/411
(100 %)
0 diff
(100 %id)
DB023877 testis .f 552 to 1110 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DC396343 testis .b 1 to 605 6 to 610   tiling clone,   610/610
(100 %)
1 diff
(99.9 %id)
DB038383 testis .vk 7 to 575 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB045446 testis .f 530 to 1094 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB046560 testis .f 558 to 1122 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB046761 testis .wo 19 to 587 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB075798 testis .wu 1 to 547 2 to 548   tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
DC404984 thymus .vu 1 to 554 1 to 554 exact     554/554
(100 %)
0 diff
(100 %id)
DB113404 thymus .wo 27 to 605 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BP363956 lung .vn 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
TI_149273777   .c 688 to 1588 90 to 983   AAA Submitted on the opposite strand 894/983
(90 %)
26 diff
(97.4 %id)
TI_149276188   .vo 56 to 814 840 to 88   tiling clone, AAA   753/953
(79 %)
12 diff
(98.8 %id)
TI_149280464   .d 681 to 1350 795 to 126       670/796
(84 %)
2 diff
(99.8 %id)
TI_149283769   .c 688 to 1396 82 to 790     Submitted on the opposite strand 709/795
(89 %)
13 diff
(98.4 %id)
TI_149290804   .wn 610 to 1348 829 to 92 P2X K3R R5A P6Q N7H ... AAA   738/982
(75 %)
5 diff
(99.5 %id)
TI_149299080   .wn 1162 to 1955 879 to 91   AAA   789/952
(82 %)
9 diff
(99.1 %id)
TI_149305273   .vz 40 to 796 847 to 94 A2S H3R V4R G5S S6R ... AAA   754/922
(81 %)
7 diff
(99.3 %id)
TI_149305658   .a 662 to 1412 99 to 849     Submitted on the opposite strand 751/1063
(70 %)
12 diff
(98.9 %id)
TI_149306649   .vo 2 to 814 894 to 89 A5L H6T V7R G8S S9R ... tiling clone, AAA   806/956
(84 %)
20 diff
(98.0 %id)
TI_149306815   .c 735 to 1511 77 to 867     Submitted on the opposite strand 791/1083
(73 %)
36 diff
(96.7 %id)
TI_149307716   .vp 139 to 916 861 to 89   tiling clone, AAA   773/945
(81 %)
10 diff
(99.0 %id)
TI_149314196   .vg 52 to 1006 1028 to 82   tiling clone, AAA   947/1002
(94 %)
13 diff
(98.8 %id)
TI_149314348   .d 449 to 1354 978 to 82   AAA   897/984
(91 %)
15 diff
(98.5 %id)
TI_154023823   .d 698 to 1354 691 to 30   AAA   662/723
(91 %)
26 diff
(96.5 %id)
TI_154045202   .d 597 to 1354 837 to 85   AAA   753/936
(80 %)
12 diff
(98.8 %id)
TI_154130873   .vo 1 to 812 904 to 94 A5L H6T V7S G8A S9P ... tiling clone, AAA   811/974
(83 %)
19 diff
(98.1 %id)
TI_154170628   .f 531 to 1291 80 to 830       751/822
(91 %)
23 diff
(97.3 %id)
TI_154193303   .h 1 to 876 51 to 925   tiling clone,   875/882
(99 %)
18 diff
(98.0 %id)
TI_159696408   .wn 654 to 1348 732 to 39 P2A K3* AAA   694/1012
(68 %)
10 diff
(99.1 %id)
TI_159696541   .d 772 to 1352 689 to 109   AAA   581/807
(71 %)
1 diff
(99.9 %id)
TI_227715304   .a 803 to 1644 937 to 106   AAA   832/985
(84 %)
11 diff
(98.9 %id)
BP367015 thymus .f 586 to 1166 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DB200232 trachea .c 647 to 1109 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
BP370387 testis .wo 14 to 572 1 to 558       558/558
(100 %)
6 diff
(99.0 %id)
BQ010523 placenta .e 1131 to 1393 280 to 18   AAA   263/263
(100 %)
4 diff
(98.5 %id)
BU674689 lung, Primary Lung Epithelial Cells .d 725 to 1354 646 to 17   AAA   630/630
(100 %)
0 diff
(100 %id)
BM968937 lung, Primary Lung Epithelial Cells .vo 182 to 814 650 to 17   tiling clone, AAA   634/634
(100 %)
2 diff
(99.7 %id)
BM968212 lung, Primary Lung Epithelial Cells .c 685 to 1374 19 to 709     Submitted on the opposite strand 691/697
(99 %)
4 diff
(99.5 %id)
BU679243 lung, Primary Lung Epithelial Cells .d 735 to 1350 638 to 23       616/638
(96 %)
0 diff
(100 %id)
BM984184 lung, Primary Lung Epithelial Cells .c 685 to 1291 19 to 626     Submitted on the opposite strand 608/608
(100 %)
5 diff
(99.2 %id)
BU685978 lung, Primary Lung Epithelial Cells .a 662 to 1404 26 to 767     Submitted on the opposite strand 742/750
(98 %)
10 diff
(98.7 %id)
CB851370 lung, Primary Lung Epithelial Cells .vs 267 to 831 581 to 17   AAA   565/565
(100 %)
4 diff
(99.3 %id)
BU685645 lung, Primary Lung Epithelial Cells .vz 116 to 796 697 to 17   AAA   681/681
(100 %)
1 diff
(99.9 %id)
BU686626 lung, Primary Lung Epithelial Cells .c 735 to 1319 21 to 605     Submitted on the opposite strand 585/605
(96 %)
12 diff
(98.1 %id)
BM979445 lung, Primary Lung Epithelial Cells .vp 272 to 916 661 to 17   AAA   645/645
(100 %)
0 diff
(100 %id)
BM970197 lung .d 900 to 1354 471 to 17   AAA   455/463
(98 %)
0 diff
(100 %id)
BU681866 lung .wn 744 to 1348 624 to 19   AAA   606/606
(100 %)
1 diff
(99.9 %id)
BU688031 lung .d 959 to 1352 410 to 17   AAA   394/417
(94 %)
0 diff
(100 %id)
BM975557 lung, Primary Lung Cystic Fibrosis EpithelialCells .wn 1197 to 1955 775 to 19   tiling clone, AAA   757/757
(100 %)
2 diff
(99.8 %id)
CB305888 lung, Primary Lung Cystic Fibrosis EpithelialCells .vg 322 to 1006 702 to 19   tiling clone, AAA   684/684
(100 %)
1 diff
(99.9 %id)
CB306012 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 672 to 1354 699 to 17   AAA   683/683
(100 %)
0 diff
(100 %id)
CA312112 Human Lung Epithelial cells, lung .f 1724 to 2308 600 to 16   AAA   585/585
(100 %)
1 diff
(99.9 %id)
BM708253 eye, RPE and Choroid .wn 1235 to 1418 1 to 181   fully sequenced,   181/181
(100 %)
1 diff
(99.5 %id)
BU731341 eye, RPE and Choroid .wn 1388 to 1952 583 to 19   fully sequenced, AAA   565/565
(100 %)
1 diff
(99.9 %id)
BM695950 eye, human retina .e 1110 to 1395 1 to 286   AAA   286/286
(100 %)
0 diff
(100 %id)
BM688686 eye, optic nerve .k 1227 to 1668 51 to 492   fully sequenced,   442/492
(89 %)
10 diff
(98.0 %id)
BU727054 eye, optic nerve .k 1464 to 1679 234 to 19   fully sequenced, AAA   216/216
(100 %)
1 diff
(99.6 %id)
BM687607 eye, eye anterior segment .vz 326 to 798 1 to 471       471/471
(100 %)
7 diff
(98.6 %id)
BM704996 eye, lens .d 508 to 925 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
BM705023 eye, lens .d 767 to 1272 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BM700435 eye, lens .vv 1 to 497 1 to 497   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
BM717502 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 756 to 1352 1 to 597   AAA   597/597
(100 %)
1 diff
(99.9 %id)
BM713541 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 611 to 1025 1 to 415   fully sequenced,   415/415
(100 %)
1 diff
(99.8 %id)
BU739568 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 964 to 1354 407 to 17   fully sequenced, AAA   391/391
(100 %)
0 diff
(100 %id)
BM678254 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1778 to 2308 549 to 19   fully sequenced, AAA   531/531
(100 %)
0 diff
(100 %id)
BM725643 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1727 to 1808 1 to 82   fully sequenced,   82/82
(100 %)
0 diff
(100 %id)
BM929709 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .wn 1215 to 1745 1 to 531       531/531
(100 %)
7 diff
(98.7 %id)
BM929711 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .wn 1215 to 1949 1 to 735       735/735
(100 %)
5 diff
(99.4 %id)
BM683512 eye, fetal eye .vq 406 to 996 609 to 19   tiling clone, fully sequenced, AAA   591/591
(100 %)
0 diff
(100 %id)
BM718468 eye, fetal eye .vq 1 to 436 1 to 436   tiling clone, fully sequenced,   436/436
(100 %)
0 diff
(100 %id)
CA438975 lung, Lung Focal Fibrosis .wn 1356 to 1949 612 to 19   AAA   594/594
(100 %)
3 diff
(99.5 %id)
BQ447676 Knee, Osteoarthritic Cartilage .b 5492 to 6149 670 to 17   AAA   654/654
(100 %)
7 diff
(99.0 %id)
CA412044 Chondrosarcoma Grade II, Left Pelvis .d 680 to 1354 693 to 19   AAA   675/675
(100 %)
1 diff
(99.9 %id)
BQ574990 Chondrosarcoma Grade II, Left Pelvis .wn 1183 to 1952 784 to 19   AAA   766/766
(100 %)
4 diff
(99.5 %id)
BQ772538 Chondrosarcoma Cell line .wn 735 to 1348 633 to 19   AAA   615/628
(97 %)
4 diff
(99.4 %id)
BQ772618 Chondrosarcoma Cell line .d 760 to 1352 607 to 17   AAA   593/601
(98 %)
3 diff
(99.6 %id)
BU615672 cell lines, Chondrosarcoma .wn 666 to 1360 711 to 19 P2X R5G N7T T8P M9* AAA   693/693
(100 %)
1 diff
(99.9 %id)
CA424924 cell lines, Chondrosarcoma .wn 684 to 1348 681 to 19 P2X R5G N7T T8P M9* AAA   663/663
(100 %)
3 diff
(99.6 %id)
CA420470 Bone, Enchondroma cell line .wn 879 to 1367 507 to 19   AAA   489/489
(100 %)
4 diff
(99.2 %id)
CA417916 Bone, Human Chondrosarcoma Cell Line .vs 237 to 829 609 to 17   tiling clone, AAA   593/593
(100 %)
1 diff
(99.9 %id)
CN480553 Cell Line, Chondrosarcoma .d 772 to 1352 597 to 17   AAA   581/590
(98 %)
1 diff
(99.9 %id)
BU616800 Cell Line, Chondrosarcoma .d 674 to 1354 697 to 17   AAA   681/681
(100 %)
2 diff
(99.8 %id)
BU622322 Cell Line, Chondrosarcoma .d 693 to 1354 678 to 17   AAA   662/662
(100 %)
0 diff
(100 %id)
BU631445 cell lines, Chondrosarcoma .d 716 to 1354 657 to 19   AAA   639/639
(100 %)
1 diff
(99.9 %id)
CA422669 cell lines, Chondrosarcoma .wn 720 to 1360 662 to 19   AAA   644/644
(100 %)
4 diff
(99.4 %id)
BU632483 cell lines, Chondrosarcoma .d 716 to 1354 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
BU620164 cell lines, Chondrosarcoma .wn 759 to 1348 608 to 19   AAA   590/590
(100 %)
3 diff
(99.5 %id)
BU621404 cell lines, Chondrosarcoma .wn 720 to 1360 659 to 19   AAA   641/641
(100 %)
0 diff
(100 %id)
BU622636 cell lines, Chondrosarcoma .wn 852 to 1348 515 to 19   AAA   497/497
(100 %)
2 diff
(99.6 %id)
BU633620 cell lines, Chondrosarcoma .d 708 to 1354 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
BU634113 cell lines, Chondrosarcoma .wn 667 to 1348 700 to 19 R136H AAA   682/682
(100 %)
2 diff
(99.8 %id)
CD365780 Alveolar Macrophage, lung .d 601 to 1354 768 to 19   AAA   750/750
(100 %)
4 diff
(99.5 %id)
TI_151717327   .d 796 to 1352 667 to 108   AAA   560/955
(58 %)
12 diff
(98.8 %id)
BU948724 Pancreas, Purified pancreatic islet .d 964 to 1353 390 to 1   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
BU948976 Pancreas, Purified pancreatic islet .d 748 to 1025 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
BU948976 IMAGE:6127642 OGFOD2andARL6IP4.dAug10 1025 278 IMAGE:6127642     278 0
BU787410 IMAGE:6128188 OGFOD2andARL6IP4.cAug10 1395 592 IMAGE:6128188 Inverted   592 1
BU787410 IMAGE:6128188 OGFOD2andARL6IP4.cAug10 1395 592 IMAGE:6128188 Inverted   592 1
BU787688 IMAGE:6128188__1 OGFOD2andARL6IP4.dAug10 1328 8 IMAGE:6128188__1 Inverted   573 0
BU787688 IMAGE:6128188__1 OGFOD2andARL6IP4.dAug10 1328 8 IMAGE:6128188__1 Inverted   573 0
BU786073 IMAGE:6129632 OGFOD2andARL6IP4.dAug10 1209 619 IMAGE:6129632 Inverted   579 6
BU786073 IMAGE:6129632 OGFOD2andARL6IP4.dAug10 1209 619 IMAGE:6129632 Inverted   579 6
BU947280 IMAGE:6129632__1 OGFOD2andARL6IP4.dAug10 1358 5 IMAGE:6129632__1 Inverted   622 1
BU947280 IMAGE:6129632__1 OGFOD2andARL6IP4.dAug10 1358 5 IMAGE:6129632__1 Inverted   622 1
BU951090 IMAGE:6132290 OGFOD2andARL6IP4.dAug10 961 497 IMAGE:6132290     497 0
BU951090 IMAGE:6132290 OGFOD2andARL6IP4.dAug10 961 497 IMAGE:6132290     497 0
BU952530 IMAGE:6132290 OGFOD2andARL6IP4.dAug10 1354 6 IMAGE:6132290     424 1
BU952530 IMAGE:6132290 OGFOD2andARL6IP4.dAug10 1354 6 IMAGE:6132290     424 1
BU188353 IMAGE:6151124 OGFOD2andARL6IP4.dAug10 1064 676 IMAGE:6151124     676 9
BU188353 IMAGE:6151124 OGFOD2andARL6IP4.dAug10 1064 676 IMAGE:6151124     676 9
BQ426034 IMAGE:6158832 OGFOD2andARL6IP4.cAug10 1427 795 IMAGE:6158832     795 20
BQ426034 IMAGE:6158832 OGFOD2andARL6IP4.cAug10 1427 795 IMAGE:6158832     795 20
BU191556 IMAGE:6254145 OGFOD2andARL6IP4.fAug10 1425 853 IMAGE:6254145     852 27
BU191556 IMAGE:6254145 OGFOD2andARL6IP4.fAug10 1425 853 IMAGE:6254145     852 27
BQ670852 IMAGE:6255105 OGFOD2andARL6IP4.dAug10 1279 516 IMAGE:6255105     516 1
BQ670852 IMAGE:6255105 OGFOD2andARL6IP4.dAug10 1279 516 IMAGE:6255105     516 1
BQ671741 IMAGE:6255746 OGFOD2andARL6IP4.eAug10 1399 491 IMAGE:6255746     491 6
BQ671741 IMAGE:6255746 OGFOD2andARL6IP4.eAug10 1399 491 IMAGE:6255746     491 6
BQ643520 IMAGE:6268331 OGFOD2andARL6IP4.qAug10 801 806 IMAGE:6268331     806 15
BQ643520 IMAGE:6268331 OGFOD2andARL6IP4.qAug10 801 806 IMAGE:6268331     806 15
BQ653070 IMAGE:6271047 OGFOD2andARL6IP4.vaAug10 717 747 IMAGE:6271047     728 36
BQ653070 IMAGE:6271047 OGFOD2andARL6IP4.vaAug10 717 747 IMAGE:6271047     728 36
BQ670612 IMAGE:6276344 OGFOD2andARL6IP4.fAug10 1098 520 IMAGE:6276344     520 5
BQ670612 IMAGE:6276344 OGFOD2andARL6IP4.fAug10 1098 520 IMAGE:6276344     520 5
BQ668608 IMAGE:6276896 OGFOD2andARL6IP4.aAug10 946 464 IMAGE:6276896     464 15
BQ668608 IMAGE:6276896 OGFOD2andARL6IP4.aAug10 946 464 IMAGE:6276896     464 15
BQ647333 IMAGE:6284586 OGFOD2andARL6IP4.qAug10 912 915 IMAGE:6284586     915 22
BQ647333 IMAGE:6284586 OGFOD2andARL6IP4.qAug10 912 915 IMAGE:6284586     915 22
BQ890325 IMAGE:6291056 OGFOD2andARL6IP4.cAug10 1298 633 IMAGE:6291056     633 15
BQ890325 IMAGE:6291056 OGFOD2andARL6IP4.cAug10 1298 633 IMAGE:6291056     633 15
BQ711564 IMAGE:6301078 OGFOD2andARL6IP4.dAug10 1193 818 IMAGE:6301078     818 27
BQ882613 IMAGE:6302130 OGFOD2andARL6IP4.dAug10 1354 663 IMAGE:6302130     663 1
BQ641858 IMAGE:6305740 OGFOD2andARL6IP4.dAug10 1352 663 IMAGE:6305740     663 4
BQ641858 IMAGE:6305740 OGFOD2andARL6IP4.dAug10 1352 663 IMAGE:6305740     663 4
BU501436 IMAGE:6338154 OGFOD2andARL6IP4.cAug10 1589 887 IMAGE:6338154     887 10
BU501436 IMAGE:6338154 OGFOD2andARL6IP4.cAug10 1589 887 IMAGE:6338154     887 10
BU150659 IMAGE:6339167 OGFOD2andARL6IP4.dAug10 810 818 IMAGE:6339167     818 36
BU150659 IMAGE:6339167 OGFOD2andARL6IP4.dAug10 810 818 IMAGE:6339167     818 36
BQ918931 IMAGE:6370507 OGFOD2andARL6IP4.cAug10 1508 857 IMAGE:6370507     857 6
BQ918931 IMAGE:6370507 OGFOD2andARL6IP4.cAug10 1508 857 IMAGE:6370507     857 6
BQ927494 IMAGE:6384088 OGFOD2andARL6IP4.dAug10 1281 912 IMAGE:6384088     912 41
BQ927494 IMAGE:6384088 OGFOD2andARL6IP4.dAug10 1281 912 IMAGE:6384088     912 41
BQ927874 IMAGE:6384244 OGFOD2andARL6IP4.dAug10 1064 645 IMAGE:6384244     645 10
BQ927874 IMAGE:6384244 OGFOD2andARL6IP4.dAug10 1064 645 IMAGE:6384244     645 10
BQ935674 IMAGE:6384475 OGFOD2andARL6IP4.dAug10 1277 895 IMAGE:6384475     895 22
BQ935674 IMAGE:6384475 OGFOD2andARL6IP4.dAug10 1277 895 IMAGE:6384475     895 22
BQ943601 IMAGE:6384736 OGFOD2andARL6IP4.vcAug10 1007 842 IMAGE:6384736     842 10
BQ943601 IMAGE:6384736 OGFOD2andARL6IP4.vcAug10 1007 842 IMAGE:6384736     842 10
BQ941529 IMAGE:6422987 OGFOD2andARL6IP4.cAug10 1588 811 IMAGE:6422987     811 1
BQ941529 IMAGE:6422987 OGFOD2andARL6IP4.cAug10 1588 811 IMAGE:6422987     811 1
BU509220 IMAGE:6503778 OGFOD2andARL6IP4.wnAug10 1419 825 IMAGE:6503778     825 21
BU509220 IMAGE:6503778 OGFOD2andARL6IP4.wnAug10 1419 825 IMAGE:6503778     825 21
BU526490 IMAGE:6536171 OGFOD2andARL6IP4.dAug10 1354 772 IMAGE:6536171     764 6
BU526490 IMAGE:6536171 OGFOD2andARL6IP4.dAug10 1354 772 IMAGE:6536171     764 6
BU526554 IMAGE:6536244 OGFOD2andARL6IP4.fAug10 1493 922 IMAGE:6536244     914 9
BU526554 IMAGE:6536244 OGFOD2andARL6IP4.fAug10 1493 922 IMAGE:6536244     914 9
BU542276 IMAGE:6574099 OGFOD2andARL6IP4.iAug10 822 807 IMAGE:6574099     807 14
BU542276 IMAGE:6574099 OGFOD2andARL6IP4.iAug10 822 807 IMAGE:6574099     807 14
BU552522 IMAGE:6576315 OGFOD2andARL6IP4.vcAug10 1056 903 IMAGE:6576315     903 9
BU552522 IMAGE:6576315 OGFOD2andARL6IP4.vcAug10 1056 903 IMAGE:6576315     903 9
BU552615 IMAGE:6576423 OGFOD2andARL6IP4.iAug10 914 899 IMAGE:6576423     899 8
BU552615 IMAGE:6576423 OGFOD2andARL6IP4.iAug10 914 899 IMAGE:6576423     899 8
BU553829 IMAGE:6580978 OGFOD2andARL6IP4.dAug10 1271 908 IMAGE:6580978     908 33
BU553829 IMAGE:6580978 OGFOD2andARL6IP4.dAug10 1271 908 IMAGE:6580978     908 33
BU564691 IMAGE:6602819 OGFOD2andARL6IP4.dAug10 1354 478 IMAGE:6602819     478 7
CA866709 IMAGE:6608088 OGFOD2andARL6IP4.vsAug10 572 530 IMAGE:6608088     530 0
CA866709 IMAGE:6608088 OGFOD2andARL6IP4.vsAug10 572 530 IMAGE:6608088     530 0
CA866966 IMAGE:6608088 OGFOD2andARL6IP4.vsAug10 830 4 IMAGE:6608088     320 0
CA866966 IMAGE:6608088 OGFOD2andARL6IP4.vsAug10 830 4 IMAGE:6608088     320 0
CA868051 IMAGE:6608685 OGFOD2andARL6IP4.veAug10 847 515 IMAGE:6608685     515 0
CA868051 IMAGE:6608685 OGFOD2andARL6IP4.veAug10 847 515 IMAGE:6608685     515 0
CA868300 IMAGE:6608685 OGFOD2andARL6IP4.veAug10 1309 4 IMAGE:6608685     509 0
CA868300 IMAGE:6608685 OGFOD2andARL6IP4.veAug10 1309 4 IMAGE:6608685     509 0
BU858218 IMAGE:6648174 OGFOD2andARL6IP4.veAug10 905 714 IMAGE:6648174     684 20
BU858218 IMAGE:6648174 OGFOD2andARL6IP4.veAug10 905 714 IMAGE:6648174     684 20
CX870403 IMAGE:7475223 OGFOD2andARL6IP4.sAug10 669 669 IMAGE:7475223     669 0
CX870960 IMAGE:7475781 OGFOD2andARL6IP4.fAug10 1314 763 IMAGE:7475781     763 0
DN602277 IMAGE:7482927 OGFOD2andARL6IP4.fAug10 1365 813 IMAGE:7482927     794 6
CV807455 IMAGE:7501588 OGFOD2andARL6IP4.woAug10 737 712 IMAGE:7501588     712 0
CV807455 IMAGE:7501588 OGFOD2andARL6IP4.woAug10 737 712 IMAGE:7501588     712 0
CV805116 IMAGE:7501696 OGFOD2andARL6IP4.vcAug10 792 705 IMAGE:7501696     705 14
CV805116 IMAGE:7501696 OGFOD2andARL6IP4.vcAug10 792 705 IMAGE:7501696     705 14
CV803535 IMAGE:7505310 OGFOD2andARL6IP4.aAug10 1354 691 IMAGE:7505310     691 7
CV803535 IMAGE:7505310 OGFOD2andARL6IP4.aAug10 1354 691 IMAGE:7505310     691 7
DR156255 IMAGE:7964851 OGFOD2andARL6IP4.hAug10 1013 670 IMAGE:7964851     670 0
CB594868 IMAGE:30255162 OGFOD2andARL6IP4.fAug10 1447 875 IMAGE:30255162     875 10
CB992528 IMAGE:30330557 OGFOD2andARL6IP4.aAug10 1284 671 IMAGE:30330557     645 12
CB992528 IMAGE:30330557 OGFOD2andARL6IP4.aAug10 1284 671 IMAGE:30330557     645 12
CB994415 IMAGE:30334179 OGFOD2andARL6IP4.vhAug10 719 760 IMAGE:30334179     733 31
CB994415 IMAGE:30334179 OGFOD2andARL6IP4.vhAug10 719 760 IMAGE:30334179     733 31
CB994935 IMAGE:30335208 OGFOD2andARL6IP4.vhAug10 614 642 IMAGE:30335208     615 8
CB994935 IMAGE:30335208 OGFOD2andARL6IP4.vhAug10 614 642 IMAGE:30335208     615 8
CB991294 IMAGE:30336526 OGFOD2andARL6IP4.vhAug10 426 453 IMAGE:30336526     425 7
CB991294 IMAGE:30336526 OGFOD2andARL6IP4.vhAug10 426 453 IMAGE:30336526     425 7
CB961420 IMAGE:30348217 OGFOD2andARL6IP4.aAug10 1284 672 IMAGE:30348217     646 15
CB961420 IMAGE:30348217 OGFOD2andARL6IP4.aAug10 1284 672 IMAGE:30348217     646 15
CF127647 IMAGE:30552867 OGFOD2andARL6IP4.cAug10 1192 710 IMAGE:30552867     710 3
CF127647 IMAGE:30552867 OGFOD2andARL6IP4.cAug10 1192 710 IMAGE:30552867     710 3
DA617604 IMR322017347 OGFOD2andARL6IP4.fAug10 1189 578 IMR322017347     577 0
TI_57220773 INCYTE_603029819 OGFOD2andARL6IP4.kAug10 918 960 INCYTE_603029819     894 26
TI_57202076 INCYTE_603040317 OGFOD2andARL6IP4.wnAug10 1347 777 INCYTE_603040317     753 12
TI_57147188 INCYTE_603044065 OGFOD2andARL6IP4.cAug10 1479 782 INCYTE_603044065     756 12
TI_57150410 INCYTE_603048027 OGFOD2andARL6IP4.fAug10 1426 964 INCYTE_603048027     897 25
TI_57177519 INCYTE_603052384 OGFOD2andARL6IP4.vxAug10 901 935 INCYTE_603052384     908 31
TI_44459985 INCYTE_603062109__1 OGFOD2andARL6IP4.gAug10 1743 6 INCYTE_603062109__1     671 0
TI_57233480 INCYTE_603064844 OGFOD2andARL6IP4.fAug10 1136 668 INCYTE_603064844     608 36
TI_57234888 INCYTE_603066682 OGFOD2andARL6IP4.vkAug10 821 839 INCYTE_603066682     806 12
TI_57235947 INCYTE_603068061 OGFOD2andARL6IP4.vlAug10 2494 828 INCYTE_603068061     795 11
TI_57236322 INCYTE_603068606 OGFOD2andARL6IP4.fAug10 1240 716 INCYTE_603068606     660 54
TI_57237229 INCYTE_603069953 OGFOD2andARL6IP4.gAug10 729 724 INCYTE_603069953     698 14
TI_57237540 INCYTE_603070381 OGFOD2andARL6IP4.vmAug10 809 836 INCYTE_603070381     805 11
TI_57170131 INCYTE_603071937 OGFOD2andARL6IP4.fAug10 1558 1009 INCYTE_603071937     981 38
TI_57177366 INCYTE_603080991 OGFOD2andARL6IP4.fAug10 1373 878 INCYTE_603080991     817 15
TI_57162973 INCYTE_603083275 OGFOD2andARL6IP4.dAug10 1221 869 INCYTE_603083275     834 14
TI_57238830 INCYTE_603176916 OGFOD2andARL6IP4.kAug10 770 794 INCYTE_603176916     773 16
TI_57238959 INCYTE_603177090 OGFOD2andARL6IP4.bAug10 5039 873 INCYTE_603177090     842 50
TI_57243532 INCYTE_603183409 OGFOD2andARL6IP4.bAug10 4809 961 INCYTE_603183409     934 51
TI_45212992 INCYTE_603247740 OGFOD2andARL6IP4.cAug10 1245 684 INCYTE_603247740     600 7
TI_44349199 INCYTE_603254147 OGFOD2andARL6IP4.vsAug10 821 913 INCYTE_603254147     832 22
TI_44343877 INCYTE_603292818 OGFOD2andARL6IP4.waAug10 832 904 INCYTE_603292818     814 21
TI_44344592 INCYTE_603293682 OGFOD2andARL6IP4.vcAug10 716 795 INCYTE_603293682     720 11
TI_44345414 INCYTE_603294642 OGFOD2andARL6IP4.waAug10 770 842 INCYTE_603294642     756 10
TI_57230334 INCYTE_603395006 OGFOD2andARL6IP4.oAug10 887 988 INCYTE_603395006     893 29
TI_59384447 INCYTE_603630291 OGFOD2andARL6IP4.dAug10 1354 677 INCYTE_603630291     622 5
TI_59390853 INCYTE_603648626 OGFOD2andARL6IP4.fAug10 1395 918 INCYTE_603648626     824 8
BP279509 KGR05270 OGFOD2andARL6IP4.fAug10 563 564 KGR05270     564 4
DA632297 KIDNE2013855 OGFOD2andARL6IP4.fAug10 1138 586 KIDNE2013855     585 0
CB128843 L5HLK1-12-E02 OGFOD2andARL6IP4.vgAug10 627 627 L5HLK1-12-E02     627 2
CB116913 L6ChoCK0-19-E02 OGFOD2andARL6IP4.vgAug10 527 527 L6ChoCK0-19-E02     527 2
CB129995 L11SNU354-9-C04 OGFOD2andARL6IP4.vwAug10 609 609 L11SNU354-9-C04     609 0
CB145562 L11SNU354s1-14-G08 OGFOD2andARL6IP4.cAug10 958 339 L11SNU354s1-14-G08     339 1
CB142899 L11SNU354s1-20-D04 OGFOD2andARL6IP4.fAug10 1032 477 L11SNU354s1-20-D04     477 2
CB141858 L11SNU354s1-24-H09 OGFOD2andARL6IP4.cAug10 962 327 L11SNU354s1-24-H09     327 2
CB144421 L11SNU354s1-25-H02 OGFOD2andARL6IP4.cAug10 1084 466 L11SNU354s1-25-H02     466 2
BP297107 MPC02551 OGFOD2andARL6IP4.fAug10 1192 573 MPC02551     573 3
BP299927 MPC09493 OGFOD2andARL6IP4.fAug10 1133 581 MPC09493     581 0
CD580469 MPMGp800A12558 OGFOD2andARL6IP4.pAug10 850 852 MPMGp800A12558     852 12
CD579492 MPMGp800F12597 OGFOD2andARL6IP4.dAug10 1039 675 MPMGp800F12597     675 12
CD579510 MPMGp800F12597__1 OGFOD2andARL6IP4.dAug10 1039 675 MPMGp800F12597__1     675 12
DR421759 nav03d08 OGFOD2andARL6IP4.aAug10 1314 639 nav03d08     639 1
DR421759 nav03d08 OGFOD2andARL6IP4.aAug10 1314 639 nav03d08     639 1
DA665818 NB9N42001493 OGFOD2andARL6IP4.vyAug10 514 515 NB9N42001493     514 2
EB386948 nbj23c08 OGFOD2andARL6IP4.aAug10 1455 815 nbj23c08     815 0
EB386948 nbj23c08 OGFOD2andARL6IP4.aAug10 1455 815 nbj23c08     815 0
DA678566 NHNPC2000247 OGFOD2andARL6IP4.fAug10 1118 568 NHNPC2000247     567 0
AI752542 NHTBC_cn17c05 OGFOD2andARL6IP4.dAug10 738 347 NHTBC_cn17c05     339 0
AI752542 NHTBC_cn17c05 OGFOD2andARL6IP4.dAug10 738 347 NHTBC_cn17c05     339 0
NM_016638.2 NM_016638 OGFOD2andARL6IP4.cAug10 1595 1321 NM_016638     1321 3
NM_018694.2 NM_018694 OGFOD2andARL6IP4.aAug10 1651 1378 NM_018694     1378 3
NM_024623.1 NM_024623 OGFOD2andARL6IP4.nAug10 2079 2080 NM_024623     2080 3
NM_001002251.1 NM_001002251 OGFOD2andARL6IP4.dAug10 1361 1354 NM_001002251     1354 3
NM_001002252.1 NM_001002252 OGFOD2andARL6IP4.eAug10 1402 1402 NM_001002252     1402 3
DB367959 NT2RP3001518 OGFOD2andARL6IP4.dAug10 1358 1 NT2RP3001518     486 3
DA749959 NT2RP7015578 OGFOD2andARL6IP4.wgAug10 619 564 NT2RP7015578     563 0
AU136439 PLACE1004274 OGFOD2andARL6IP4.nAug10 734 742 PLACE1004274     739 14
AU156723 PLACE1004274 OGFOD2andARL6IP4.nAug10 2079 1 PLACE1004274     545 17
BP324148 PNC06143 OGFOD2andARL6IP4.cAug10 1176 531 PNC06143     531 7
BP330828 RCT07561 OGFOD2andARL6IP4.fAug10 1130 581 RCT07561     581 3
CR991128 RZPDp9016B216 OGFOD2andARL6IP4.wiAug10 543 545 RZPDp9016B216     545 6
CR980315 RZPDp9016B2441 OGFOD2andARL6IP4.cAug10 1586 821 RZPDp9016B2441     821 2
CR975683 RZPDp9016C089 OGFOD2andARL6IP4.cAug10 1195 531 RZPDp9016C089     531 0
CR985644 RZPDp9016D2418 OGFOD2andARL6IP4.fAug10 743 169 RZPDp9016D2418     169 5
CR988772 RZPDp9016E154 OGFOD2andARL6IP4.cAug10 1391 746 RZPDp9016E154     729 11
CR988345 RZPDp9017C2037 OGFOD2andARL6IP4.uAug10 663 618 RZPDp9017C2037     618 0
CR981251 RZPDp9017C2411 OGFOD2andARL6IP4.lAug10 820 607 RZPDp9017C2411     607 1
CR990778 RZPDp9017J1420 OGFOD2andARL6IP4.kAug10 472 446 RZPDp9017J1420     446 12
CR988774 RZPDp9017J1925 OGFOD2andARL6IP4.cAug10 1229 594 RZPDp9017J1925     594 6
CT003672 RZPDp9017N193 OGFOD2andARL6IP4.uAug10 812 812 RZPDp9017N193     812 9
CT003609 RZPDp9017N0314 OGFOD2andARL6IP4.aAug10 1153 568 RZPDp9017N0314     509 7
CR994937 RZPDp9017O0316 OGFOD2andARL6IP4.wjAug10 707 716 RZPDp9017O0316     716 1
CR983970 RZPDp9017O0922 OGFOD2andARL6IP4.kAug10 674 650 RZPDp9017O0922     650 1
BM790492 S22SNU16n1-7-E07 OGFOD2andARL6IP4.bAug10 5953 565 S22SNU16n1-7-E07     565 1
BM790492 S22SNU16n1-7-E07 OGFOD2andARL6IP4.bAug10 5953 565 S22SNU16n1-7-E07     565 1
BM793735 S22SNU16n1-26-E11 OGFOD2andARL6IP4.whAug10 541 541 S22SNU16n1-26-E11     541 1
BM793735 S22SNU16n1-26-E11 OGFOD2andARL6IP4.whAug10 541 541 S22SNU16n1-26-E11     541 1
BM793598 S22SNU16n1-30-F07 OGFOD2andARL6IP4.dAug10 1243 459 S22SNU16n1-30-F07     459 0
BM793598 S22SNU16n1-30-F07 OGFOD2andARL6IP4.dAug10 1243 459 S22SNU16n1-30-F07     459 0
BM793930 S22SNU16n1-32-C09 OGFOD2andARL6IP4.weAug10 871 686 S22SNU16n1-32-C09     686 1
BM793930 S22SNU16n1-32-C09 OGFOD2andARL6IP4.weAug10 871 686 S22SNU16n1-32-C09     686 1
BM793504 S22SNU16n1-33-C09 OGFOD2andARL6IP4.dAug10 1345 593 S22SNU16n1-33-C09     593 0
BM793504 S22SNU16n1-33-C09 OGFOD2andARL6IP4.dAug10 1345 593 S22SNU16n1-33-C09     593 0
BM824758 S22SNU16n1-99-F08 OGFOD2andARL6IP4.wfAug10 1073 483 S22SNU16n1-99-F08     483 0
BM824758 S22SNU16n1-99-F08 OGFOD2andARL6IP4.wfAug10 1073 483 S22SNU16n1-99-F08     483 0
F27927 s4000028B10 OGFOD2andARL6IP4.cAug10 1586 364 s4000028B10     364 2
F27933 s4000028C05 OGFOD2andARL6IP4.cAug10 1586 366 s4000028C05     366 4
F25803 s4000044B10 OGFOD2andARL6IP4.dAug10 1270 281 s4000044B10     281 0
F31334 s4000114A09 OGFOD2andARL6IP4.dAug10 1154 282 s4000114A09     282 2
TI_1948084345 SC_11019_2_G6__2 OGFOD2andARL6IP4.bAug10 5833 126 SC_11019_2_G6__2     528 29
TI_1948084899 SC_11019_4_G6__2 OGFOD2andARL6IP4.eAug10 1077 125 SC_11019_4_G6__2     589 28
F36692 sH5-000019-0/D02 OGFOD2andARL6IP4.cAug10 1576 354 sH5-000019-0/D02     354 2
DC386083 SKNMC2001166 OGFOD2andARL6IP4.bAug10 487 462 SKNMC2001166     462 2
BP343061 STM06620 OGFOD2andARL6IP4.woAug10 597 583 STM06620     583 2
DA967054 STOMA2005625 OGFOD2andARL6IP4.wnAug10 569 571 STOMA2005625     570 0
BP351012 T3R02951 OGFOD2andARL6IP4.vuAug10 590 583 T3R02951     583 0
DN995613 TC102687 OGFOD2andARL6IP4.eAug10 1393 436 TC102687     436 5
DN995613 TC102687 OGFOD2andARL6IP4.eAug10 1393 436 TC102687     436 5
DN992667 TC108662 OGFOD2andARL6IP4.vcAug10 692 547 TC108662     547 10
DN992667 TC108662 OGFOD2andARL6IP4.vcAug10 692 547 TC108662     547 10
DR004628 TC112128 OGFOD2andARL6IP4.wqAug10 640 605 TC112128     605 6
DN994077 TC113364 OGFOD2andARL6IP4.sAug10 685 438 TC113364     430 6
DN994077 TC113364 OGFOD2andARL6IP4.sAug10 685 438 TC113364     430 6
BM150829 TCBAP1262__5 OGFOD2andARL6IP4.bAug10 4256 1 TCBAP1262__5     446 0
BM152832 TCBAP1262__7 OGFOD2andARL6IP4.mAug10 1129 424 TCBAP1262__7     413 7
BE246616 TCBAP4991 OGFOD2andARL6IP4.mAug10 1109 427 TCBAP4991     393 15
BM151276 TCBAP4991__1 OGFOD2andARL6IP4.bAug10 4256 1 TCBAP4991__1     346 14
DB009535 TCOLN2000386 OGFOD2andARL6IP4.bAug10 826 412 TCOLN2000386     411 0
DB023877 TESTI2005208 OGFOD2andARL6IP4.fAug10 1110 560 TESTI2005208     559 0
DC396343 TESTI2017447 OGFOD2andARL6IP4.bAug10 605 610 TESTI2017447     610 1
DB038383 TESTI2024632 OGFOD2andARL6IP4.vkAug10 575 571 TESTI2024632     570 2
DB045446 TESTI2033687 OGFOD2andARL6IP4.fAug10 1094 566 TESTI2033687     565 0
DB046560 TESTI2035144 OGFOD2andARL6IP4.fAug10 1122 566 TESTI2035144     565 0
DB046761 TESTI2035383 OGFOD2andARL6IP4.woAug10 587 570 TESTI2035383     569 0
DB075798 TESTI4019790 OGFOD2andARL6IP4.wuAug10 547 548 TESTI4019790     547 0
DC404984 THYMU2005040 OGFOD2andARL6IP4.vuAug10 554 554 THYMU2005040     554 0
DB113404 THYMU2018017 OGFOD2andARL6IP4.woAug10 605 580 THYMU2018017     579 0
BP363956 TIR02886 OGFOD2andARL6IP4.vnAug10 582 582 TIR02886     582 0
TI_149273777 TI_149273777 OGFOD2andARL6IP4.cAug10 1588 983 TI_149273777 Inverted   894 26
TI_149276188 TI_149276188 OGFOD2andARL6IP4.voAug10 814 88 TI_149276188     753 12
TI_149280464 TI_149280464 OGFOD2andARL6IP4.dAug10 1350 126 TI_149280464     670 2
TI_149283769 TI_149283769 OGFOD2andARL6IP4.cAug10 1396 790 TI_149283769 Inverted   709 13
TI_149290804 TI_149290804 OGFOD2andARL6IP4.wnAug10 1348 92 TI_149290804     738 5
TI_149299080 TI_149299080 OGFOD2andARL6IP4.wnAug10 1955 91 TI_149299080     789 9
TI_149305273 TI_149305273 OGFOD2andARL6IP4.vzAug10 796 94 TI_149305273     754 7
TI_149305658 TI_149305658 OGFOD2andARL6IP4.aAug10 1412 849 TI_149305658 Inverted   751 12
TI_149306649 TI_149306649 OGFOD2andARL6IP4.voAug10 814 89 TI_149306649     806 20
TI_149306815 TI_149306815 OGFOD2andARL6IP4.cAug10 1511 867 TI_149306815 Inverted   791 36
TI_149307716 TI_149307716 OGFOD2andARL6IP4.vpAug10 916 89 TI_149307716     773 10
TI_149314196 TI_149314196 OGFOD2andARL6IP4.vgAug10 1006 82 TI_149314196     947 13
TI_149314348 TI_149314348 OGFOD2andARL6IP4.dAug10 1354 82 TI_149314348     897 15
TI_154023823 TI_154023823 OGFOD2andARL6IP4.dAug10 1354 30 TI_154023823     662 26
TI_154045202 TI_154045202 OGFOD2andARL6IP4.dAug10 1354 85 TI_154045202     753 12
TI_154130873 TI_154130873 OGFOD2andARL6IP4.voAug10 812 94 TI_154130873     811 19
TI_154170628 TI_154170628 OGFOD2andARL6IP4.fAug10 1291 830 TI_154170628     751 23
TI_154193303 TI_154193303 OGFOD2andARL6IP4.hAug10 876 925 TI_154193303     875 18
TI_159696408 TI_159696408 OGFOD2andARL6IP4.wnAug10 1348 39 TI_159696408     694 10
TI_159696541 TI_159696541 OGFOD2andARL6IP4.dAug10 1352 109 TI_159696541     581 1
TI_227715304 TI_227715304 OGFOD2andARL6IP4.aAug10 1644 106 TI_227715304     832 11
BP367015 TMS02615 OGFOD2andARL6IP4.fAug10 1166 581 TMS02615     581 1
DB200232 TRACH2009158 OGFOD2andARL6IP4.cAug10 1109 464 TRACH2009158     463 0
BP370387 TST05532 OGFOD2andARL6IP4.woAug10 572 558 TST05532     558 6
BQ010523 UI-1-BC1-aji-a-03-0-UI OGFOD2andARL6IP4.eAug10 1393 18 UI-1-BC1-aji-a-03-0-UI     263 4
BU674689 UI-CF-DU0-aac-h-20-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-CF-DU0-aac-h-20-0-UI     630 0
BU674689 UI-CF-DU0-aac-h-20-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-CF-DU0-aac-h-20-0-UI     630 0
BM968937 UI-CF-DU1-aan-k-04-0-UI OGFOD2andARL6IP4.voAug10 814 17 UI-CF-DU1-aan-k-04-0-UI     634 2
BM968937 UI-CF-DU1-aan-k-04-0-UI OGFOD2andARL6IP4.voAug10 814 17 UI-CF-DU1-aan-k-04-0-UI     634 2
BM968212 UI-CF-DU1-aao-g-20-0-UI OGFOD2andARL6IP4.cAug10 1374 709 UI-CF-DU1-aao-g-20-0-UI Inverted   691 4
BM968212 UI-CF-DU1-aao-g-20-0-UI OGFOD2andARL6IP4.cAug10 1374 709 UI-CF-DU1-aao-g-20-0-UI Inverted   691 4
BU679243 UI-CF-DU1-aat-d-14-0-UI OGFOD2andARL6IP4.dAug10 1350 23 UI-CF-DU1-aat-d-14-0-UI     616 0
BU679243 UI-CF-DU1-aat-d-14-0-UI OGFOD2andARL6IP4.dAug10 1350 23 UI-CF-DU1-aat-d-14-0-UI     616 0
BM984184 UI-CF-DU1-abf-i-23-0-UI OGFOD2andARL6IP4.cAug10 1291 626 UI-CF-DU1-abf-i-23-0-UI Inverted   608 5
BM984184 UI-CF-DU1-abf-i-23-0-UI OGFOD2andARL6IP4.cAug10 1291 626 UI-CF-DU1-abf-i-23-0-UI Inverted   608 5
BU685978 UI-CF-DU1-adj-c-14-0-UI OGFOD2andARL6IP4.aAug10 1404 767 UI-CF-DU1-adj-c-14-0-UI Inverted   742 10
BU685978 UI-CF-DU1-adj-c-14-0-UI OGFOD2andARL6IP4.aAug10 1404 767 UI-CF-DU1-adj-c-14-0-UI Inverted   742 10
CB851370 UI-CF-DU1-adj-j-04-0-UI OGFOD2andARL6IP4.vsAug10 831 17 UI-CF-DU1-adj-j-04-0-UI     565 4
CB851370 UI-CF-DU1-adj-j-04-0-UI OGFOD2andARL6IP4.vsAug10 831 17 UI-CF-DU1-adj-j-04-0-UI     565 4
BU685645 UI-CF-DU1-adm-c-12-0-UI OGFOD2andARL6IP4.vzAug10 796 17 UI-CF-DU1-adm-c-12-0-UI     681 1
BU685645 UI-CF-DU1-adm-c-12-0-UI OGFOD2andARL6IP4.vzAug10 796 17 UI-CF-DU1-adm-c-12-0-UI     681 1
BU686626 UI-CF-DU1-adp-c-24-0-UI OGFOD2andARL6IP4.cAug10 1319 605 UI-CF-DU1-adp-c-24-0-UI Inverted   585 12
BU686626 UI-CF-DU1-adp-c-24-0-UI OGFOD2andARL6IP4.cAug10 1319 605 UI-CF-DU1-adp-c-24-0-UI Inverted   585 12
BM979445 UI-CF-DU1-adr-l-01-0-UI OGFOD2andARL6IP4.vpAug10 916 17 UI-CF-DU1-adr-l-01-0-UI     645 0
BM979445 UI-CF-DU1-adr-l-01-0-UI OGFOD2andARL6IP4.vpAug10 916 17 UI-CF-DU1-adr-l-01-0-UI     645 0
BM970197 UI-CF-EC1-abv-i-11-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-CF-EC1-abv-i-11-0-UI     455 0
BU681866 UI-CF-EC1-ach-g-15-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-CF-EC1-ach-g-15-0-UI     606 1
BU688031 UI-CF-EC1-adx-m-12-0-UI OGFOD2andARL6IP4.dAug10 1352 17 UI-CF-EC1-adx-m-12-0-UI     394 0
BM975557 UI-CF-EN1-acw-k-13-0-UI OGFOD2andARL6IP4.wnAug10 1955 19 UI-CF-EN1-acw-k-13-0-UI     757 2
BM975557 UI-CF-EN1-acw-k-13-0-UI OGFOD2andARL6IP4.wnAug10 1955 19 UI-CF-EN1-acw-k-13-0-UI     757 2
CB305888 UI-CF-EN1-aeh-c-01-0-UI OGFOD2andARL6IP4.vgAug10 1006 19 UI-CF-EN1-aeh-c-01-0-UI     684 1
CB305888 UI-CF-EN1-aeh-c-01-0-UI OGFOD2andARL6IP4.vgAug10 1006 19 UI-CF-EN1-aeh-c-01-0-UI     684 1
CB306012 UI-CF-EN1-aeh-k-18-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-CF-EN1-aeh-k-18-0-UI     683 0
CB306012 UI-CF-EN1-aeh-k-18-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-CF-EN1-aeh-k-18-0-UI     683 0
CA312112 UI-CF-FN0-afj-h-23-0-UI OGFOD2andARL6IP4.fAug10 2308 16 UI-CF-FN0-afj-h-23-0-UI     585 1
CA312112 UI-CF-FN0-afj-h-23-0-UI OGFOD2andARL6IP4.fAug10 2308 16 UI-CF-FN0-afj-h-23-0-UI     585 1
BM708253 UI-E-CI1-afu-e-07-0-UI OGFOD2andARL6IP4.wnAug10 1418 181 UI-E-CI1-afu-e-07-0-UI     181 1
BM708253 UI-E-CI1-afu-e-07-0-UI OGFOD2andARL6IP4.wnAug10 1418 181 UI-E-CI1-afu-e-07-0-UI     181 1
BU731341 UI-E-CI1-afu-e-07-0-UI OGFOD2andARL6IP4.wnAug10 1952 19 UI-E-CI1-afu-e-07-0-UI     565 1
BU731341 UI-E-CI1-afu-e-07-0-UI OGFOD2andARL6IP4.wnAug10 1952 19 UI-E-CI1-afu-e-07-0-UI     565 1
BM695950 UI-E-CL1-afa-e-19-0-UI OGFOD2andARL6IP4.eAug10 1395 286 UI-E-CL1-afa-e-19-0-UI     286 0
BM695950 UI-E-CL1-afa-e-19-0-UI OGFOD2andARL6IP4.eAug10 1395 286 UI-E-CL1-afa-e-19-0-UI     286 0
BM688686 UI-E-CQ1-acq-f-12-0-UI OGFOD2andARL6IP4.kAug10 1668 492 UI-E-CQ1-acq-f-12-0-UI     442 10
BM688686 UI-E-CQ1-acq-f-12-0-UI OGFOD2andARL6IP4.kAug10 1668 492 UI-E-CQ1-acq-f-12-0-UI     442 10
BU727054 UI-E-CQ1-acq-f-12-0-UI OGFOD2andARL6IP4.kAug10 1679 19 UI-E-CQ1-acq-f-12-0-UI     216 1
BU727054 UI-E-CQ1-acq-f-12-0-UI OGFOD2andARL6IP4.kAug10 1679 19 UI-E-CQ1-acq-f-12-0-UI     216 1
BM687607 UI-E-CR0-adh-e-12-0-UI OGFOD2andARL6IP4.vzAug10 798 471 UI-E-CR0-adh-e-12-0-UI     471 7
BM687607 UI-E-CR0-adh-e-12-0-UI OGFOD2andARL6IP4.vzAug10 798 471 UI-E-CR0-adh-e-12-0-UI     471 7
BM704996 UI-E-DW0-agg-g-07-0-UI OGFOD2andARL6IP4.dAug10 925 418 UI-E-DW0-agg-g-07-0-UI     418 2
BM704996 UI-E-DW0-agg-g-07-0-UI OGFOD2andARL6IP4.dAug10 925 418 UI-E-DW0-agg-g-07-0-UI     418 2
BM705023 UI-E-DW0-agg-k-15-0-UI OGFOD2andARL6IP4.dAug10 1272 506 UI-E-DW0-agg-k-15-0-UI     506 0
BM705023 UI-E-DW0-agg-k-15-0-UI OGFOD2andARL6IP4.dAug10 1272 506 UI-E-DW0-agg-k-15-0-UI     506 0
BM700435 UI-E-DW1-ahb-i-02-0-UI OGFOD2andARL6IP4.vvAug10 497 497 UI-E-DW1-ahb-i-02-0-UI     497 0
BM700435 UI-E-DW1-ahb-i-02-0-UI OGFOD2andARL6IP4.vvAug10 497 497 UI-E-DW1-ahb-i-02-0-UI     497 0
BM717502 UI-E-EJ0-ahn-m-08-0-UI OGFOD2andARL6IP4.dAug10 1352 597 UI-E-EJ0-ahn-m-08-0-UI     597 1
BM717502 UI-E-EJ0-ahn-m-08-0-UI OGFOD2andARL6IP4.dAug10 1352 597 UI-E-EJ0-ahn-m-08-0-UI     597 1
BM713541 UI-E-EJ0-aho-n-15-0-UI OGFOD2andARL6IP4.dAug10 1025 415 UI-E-EJ0-aho-n-15-0-UI     415 1
BM713541 UI-E-EJ0-aho-n-15-0-UI OGFOD2andARL6IP4.dAug10 1025 415 UI-E-EJ0-aho-n-15-0-UI     415 1
BU739568 UI-E-EJ0-aho-n-15-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-E-EJ0-aho-n-15-0-UI     391 0
BU739568 UI-E-EJ0-aho-n-15-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-E-EJ0-aho-n-15-0-UI     391 0
BM678254 UI-E-EJ0-aif-b-09-0-UI OGFOD2andARL6IP4.fAug10 2308 19 UI-E-EJ0-aif-b-09-0-UI     531 0
BM678254 UI-E-EJ0-aif-b-09-0-UI OGFOD2andARL6IP4.fAug10 2308 19 UI-E-EJ0-aif-b-09-0-UI     531 0
BM725643 UI-E-EJ0-aif-b-09-0-UI OGFOD2andARL6IP4.fAug10 1808 82 UI-E-EJ0-aif-b-09-0-UI     82 0
BM725643 UI-E-EJ0-aif-b-09-0-UI OGFOD2andARL6IP4.fAug10 1808 82 UI-E-EJ0-aif-b-09-0-UI     82 0
BM929709 UI-E-EJ1-ajh-o-03-0-UI OGFOD2andARL6IP4.wnAug10 1745 531 UI-E-EJ1-ajh-o-03-0-UI     531 7
BM929709 UI-E-EJ1-ajh-o-03-0-UI OGFOD2andARL6IP4.wnAug10 1745 531 UI-E-EJ1-ajh-o-03-0-UI     531 7
BM929711 UI-E-EJ1-ajh-o-07-0-UI OGFOD2andARL6IP4.wnAug10 1949 735 UI-E-EJ1-ajh-o-07-0-UI     735 5
BM929711 UI-E-EJ1-ajh-o-07-0-UI OGFOD2andARL6IP4.wnAug10 1949 735 UI-E-EJ1-ajh-o-07-0-UI     735 5
BM683512 UI-E-EO1-ajb-d-01-0-UI OGFOD2andARL6IP4.vqAug10 996 19 UI-E-EO1-ajb-d-01-0-UI     591 0
BM683512 UI-E-EO1-ajb-d-01-0-UI OGFOD2andARL6IP4.vqAug10 996 19 UI-E-EO1-ajb-d-01-0-UI     591 0
BM718468 UI-E-EO1-ajb-d-01-0-UI OGFOD2andARL6IP4.vqAug10 436 436 UI-E-EO1-ajb-d-01-0-UI     436 0
BM718468 UI-E-EO1-ajb-d-01-0-UI OGFOD2andARL6IP4.vqAug10 436 436 UI-E-EO1-ajb-d-01-0-UI     436 0
CA438975 UI-H-DI0-auu-g-23-0-UI OGFOD2andARL6IP4.wnAug10 1949 19 UI-H-DI0-auu-g-23-0-UI     594 3
CA438975 UI-H-DI0-auu-g-23-0-UI OGFOD2andARL6IP4.wnAug10 1949 19 UI-H-DI0-auu-g-23-0-UI     594 3
BQ447676 UI-H-EU1-baf-f-17-0-UI OGFOD2andARL6IP4.bAug10 6149 17 UI-H-EU1-baf-f-17-0-UI     654 7
BQ447676 UI-H-EU1-baf-f-17-0-UI OGFOD2andARL6IP4.bAug10 6149 17 UI-H-EU1-baf-f-17-0-UI     654 7
CA412044 UI-H-EZ0-bal-m-04-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-EZ0-bal-m-04-0-UI     675 1
CA412044 UI-H-EZ0-bal-m-04-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-EZ0-bal-m-04-0-UI     675 1
BQ574990 UI-H-EZ1-bbd-e-01-0-UI OGFOD2andARL6IP4.wnAug10 1952 19 UI-H-EZ1-bbd-e-01-0-UI     766 4
BQ574990 UI-H-EZ1-bbd-e-01-0-UI OGFOD2andARL6IP4.wnAug10 1952 19 UI-H-EZ1-bbd-e-01-0-UI     766 4
BQ772538 UI-H-FE0-bbq-f-21-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FE0-bbq-f-21-0-UI     615 4
BQ772618 UI-H-FE0-bbq-h-02-0-UI OGFOD2andARL6IP4.dAug10 1352 17 UI-H-FE0-bbq-h-02-0-UI     593 3
BU615672 UI-H-FE1-bdy-h-01-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FE1-bdy-h-01-0-UI     693 1
BU615672 UI-H-FE1-bdy-h-01-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FE1-bdy-h-01-0-UI     693 1
CA424924 UI-H-FE1-bee-c-12-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FE1-bee-c-12-0-UI     663 3
CA424924 UI-H-FE1-bee-c-12-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FE1-bee-c-12-0-UI     663 3
CA420470 UI-H-FG0-bcp-l-15-0-UI OGFOD2andARL6IP4.wnAug10 1367 19 UI-H-FG0-bcp-l-15-0-UI     489 4
CA420470 UI-H-FG0-bcp-l-15-0-UI OGFOD2andARL6IP4.wnAug10 1367 19 UI-H-FG0-bcp-l-15-0-UI     489 4
CA417916 UI-H-FH0-bcc-i-03-0-UI OGFOD2andARL6IP4.vsAug10 829 17 UI-H-FH0-bcc-i-03-0-UI     593 1
CA417916 UI-H-FH0-bcc-i-03-0-UI OGFOD2andARL6IP4.vsAug10 829 17 UI-H-FH0-bcc-i-03-0-UI     593 1
CN480553 UI-H-FH1-bfe-j-02-0-UI OGFOD2andARL6IP4.dAug10 1352 17 UI-H-FH1-bfe-j-02-0-UI     581 1
CN480553 UI-H-FH1-bfe-j-02-0-UI OGFOD2andARL6IP4.dAug10 1352 17 UI-H-FH1-bfe-j-02-0-UI     581 1
BU616800 UI-H-FH1-bfj-m-01-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-H-FH1-bfj-m-01-0-UI     681 2
BU616800 UI-H-FH1-bfj-m-01-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-H-FH1-bfj-m-01-0-UI     681 2
BU622322 UI-H-FH1-bfu-h-18-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-H-FH1-bfu-h-18-0-UI     662 0
BU622322 UI-H-FH1-bfu-h-18-0-UI OGFOD2andARL6IP4.dAug10 1354 17 UI-H-FH1-bfu-h-18-0-UI     662 0
BU631445 UI-H-FL0-bdl-k-14-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL0-bdl-k-14-0-UI     639 1
BU631445 UI-H-FL0-bdl-k-14-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL0-bdl-k-14-0-UI     639 1
CA422669 UI-H-FL0-bdn-e-01-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FL0-bdn-e-01-0-UI     644 4
CA422669 UI-H-FL0-bdn-e-01-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FL0-bdn-e-01-0-UI     644 4
BU632483 UI-H-FL0-bdp-i-20-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL0-bdp-i-20-0-UI     639 0
BU632483 UI-H-FL0-bdp-i-20-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL0-bdp-i-20-0-UI     639 0
BU620164 UI-H-FL1-bfw-g-07-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bfw-g-07-0-UI     590 3
BU620164 UI-H-FL1-bfw-g-07-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bfw-g-07-0-UI     590 3
BU621404 UI-H-FL1-bfz-p-10-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FL1-bfz-p-10-0-UI     641 0
BU621404 UI-H-FL1-bfz-p-10-0-UI OGFOD2andARL6IP4.wnAug10 1360 19 UI-H-FL1-bfz-p-10-0-UI     641 0
BU622636 UI-H-FL1-bgc-j-15-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bgc-j-15-0-UI     497 2
BU622636 UI-H-FL1-bgc-j-15-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bgc-j-15-0-UI     497 2
BU633620 UI-H-FL1-bgv-c-04-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL1-bgv-c-04-0-UI     647 0
BU633620 UI-H-FL1-bgv-c-04-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FL1-bgv-c-04-0-UI     647 0
BU634113 UI-H-FL1-bgw-p-19-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bgw-p-19-0-UI     682 2
BU634113 UI-H-FL1-bgw-p-19-0-UI OGFOD2andARL6IP4.wnAug10 1348 19 UI-H-FL1-bgw-p-19-0-UI     682 2
CD365780 UI-H-FT2-bjk-n-15-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FT2-bjk-n-15-0-UI     750 4
CD365780 UI-H-FT2-bjk-n-15-0-UI OGFOD2andARL6IP4.dAug10 1354 19 UI-H-FT2-bjk-n-15-0-UI     750 4
TI_151717327 UIACBCB_UI-E-DW1-ahb-i-02-0-UI OGFOD2andARL6IP4.dAug10 1352 108 UIACBCB_UI-E-DW1-ahb-i-02-0-UI     560 12
88 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt, .vu, .vv, .vw, .vx, .vy, .vz, .wa, .wb, .wc, .wd, .we, .wf, .wg, .wh, .wi, .wj, .wk, .wl, .wm, .wn, .wo, .wp, .wq, .wr, .ws, .wt-u, .wu Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI